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SUMMARY
Chronic pain is the leading cause of long-term disability. It is a condition that affects the
quality of life for its sufferers because it is frequently comorbid with anxiety, depression,
and sleep deprivation. Heterogeneity in etiology and manifestation of neuropathic pain
contribute to difficulties finding broadly effective pain management strategies. In cases
where pharmacological treatment has failed to provide relief, epidural spinal cord stimula-
tion (SCS) has emerged as an alternative intervention for intractable pain. This technology
has been in clinical use for over 50 years, yet efficacy rates have remained stagnant and
etiology-dependent. A barrier to improved efficacy is an absence of knowledge identify-
ing the mechanism by which SCS can selectively inhibit chronic, spontaneous pain. The
gate control theory presents a theoretical framework of the therapy’s mechanism of action,
but the true mechanisms remain unclear. This is further complicated by the absence of
spontaneous pain models and metrics for quantifying them.
The objective of this dissertation was to generate knowledge that leads to a better un-
derstanding of both spontaneous neuropathic pain and SCS pain relief. To do this, I first
establish links between spontaneous sensory hyperexcitability and stimulus-independent
physio-behavioral indices of pain, using a contusion model of spinal cord injury (SCI). I hy-
pothesized that greater spontaneous primary afferent activity would be observed in the SCI
model of neuropathic pain, and that it would occur alongside development of respiratory
and sleep dysfunction. My results identify functional shifts in sleep, respiration and sensory
function after SCI. Next, I used an ex vivo adult mouse spinal cord preparation to assess
axonal recruitment with SCS. A computational model was utilized to inform parameter se-
lection for examining clinically-analogous SCS with our model system. I hypothesized that
dorsal column and dorsal root axons would be recruited at the same threshold—indicative
of Aβ axons being the first recruited population with SCS. These experiments successfully
xxi
characterized the recruitment thresholds for afferents in the lumbar dorsal column, dorsal
roots, and Lissauer’s tract. A key finding was that the lowest threshold DC axons are not
primary afferent collaterals, but possibly postsynaptic dorsal column tract cell. Finally, I
tested the gate control theory by examining SCS modulation in ex vivo model of spon-
taneous pain. For these studies, I extended the spinal cord preparation to include intact
dorsal root ganglia from multiple lumbar segments and characterized spontaneous activity
in primary afferents and spinal nociceptive circuits. I hypothesized that SCS would re-
duce spontaneous activity in nociceptive circuitry during, and after SCS. Results indicated
that antidromic afferent recruitment was not sufficient to replicate prolonged modulation of
spontaneous nociceptive activity with SCS.
Together, these findings provide greater insight into the development and identification





Spinal cord stimulation (SCS) is a form of electrical neuromodulation implemented to al-
leviate neuropathic pain resistant to traditional methods of treatment. Though it has been
in clinical use for over 40 years, we still lack critical understanding of how it induces pain
relief [1][2]. This lack of understanding has been identified as a contributor to its limited
improvement in efficacy[2][3], which has resulted in the development of various preclin-
ical studies aiming to expand knowledge of its underlying mechanisms of action[4][2].
The goal of this dissertation is to delineate how axonal recruitment with SCS contributes
to modulation of spontaneous activity in the spinal cord. Below, I first describe the clas-
sification and organization of afferents in the dorsal spinal cord, to lay a foundation for
understanding the potential source of aberrant sensory signaling and the potential targets
of SCS. Next, I present clinical and preclinical evidence demonstrating the role of periph-
eral and spinal sensory circuit hyperexcitability in the development of chronic pain, with
emphasis on spontaneous activity. I then describe the clinical application of SCS as a ther-
apeutic for neuropathic pain, followed by a summary of preclinical studies contributing to
our current understanding of its mechanism of action. I close this chapter with a discussion
of remaining limitations and knowledge gaps relevant to the field; and include an outline
of aims designed to address these limitations and gaps.
1.1 Organization of Afferents in the Dorsal Spinal Cord
The spinal cord is the locus of transition between the peripheral and central nervous sys-
tems. Primary afferents of the peripheral nervous system transmit somatosensory infor-
mation about the state of our body and our environment to the spinal cord. These incom-
ing sensory signals are then processed in the spinal cord and transmitted to the brain via
1
higher-order neurons and afferents. Neural processing at the cortical region of the brain
gives meaning to the peripheral stimuli, as the Morse cord of neuronal spiking is trans-
lated to perceptions such as temperature, touch, and pain and their associated location of
occurrence. The output of cortical processing permits interactions with our environment
by initiating signals transmitted to the ventral spinal cord by pathways including direct de-
scending corticospinal efferents. Activation of ventral neurons elicit a motor response by
exciting or inhibiting an effector, such as a muscle cell.
While the spinal cord is typically regarded as a critical relay center of incoming sen-
sory and outgoing motor information to and from the brain, it also serves as integrative
center capable of modifying sensory encoding and as a processing center that permits rapid
responsive interactions that generate the various reflex motor responses. Dysfunction of
primary afferents and their consequent actions in neuronal circuits in the spinal cord have
been associated with various etiologies of chronic pain, thus serving as a target for ther-
apeutic interventions. Understanding the potential mechanisms underlying the effects of
such therapeutics requires knowledge of the system organization and function along with
understanding of the aberrant shifts that occur following injury or disease.
1.1.1 Peripheral branches of primary afferents
Primary afferents are the first-order neurons of sensory processing. These pseudo-unipolar
cells have specialized dendrites called nerve endings that selectively transduce mechanical,
chemical, or thermal information from its receptive field. The collective cell bodies of
primary afferents from peripheral nerves within a dermatome, a specific cutaneous region
of the body (see Figure 1.1) , reside in a single dorsal root ganglion (DRG) and have axons
that travel to the spinal cord via the dorsal root (DR) of a segmental spinal nerve ([5]; see
Figure 1.2) . This organization is conserved across the 8 cervical, 12 thoracic, 5 lumbar,
and 5 sacral spinal cord segments.
2
Figure 1.1: Somatotopic diagram of dermatomes and associated spinal nerves.
A dermatome is a cutaneous region of the body that receives sensory innervation from primary
afferents residing in a single segmental dorsal root. Cervical roots innervate regions the arms, neck,
and head. Thoracic roots innervation regions of the arms and trunk. Lumbar and sacral roots
innervate regions of the lower back and legs. Figure from: Felten 2016 [5].
Perceptual discrimination of stimulus-types, such as the difference between pressure
and pain, is aided by the division of somatosensory transduction across different classes
of afferents. Cutaneous primary afferents have historically been classified by their axon
diameter and degree of myelination (i.e. speed of impulse conduction) along with their
functional specialization (i.e. the type of stimuli producing activation). The main clas-
sifications are myelinated A fibers (Aα, Aβ, Aδ–in decreasing order of myelination) and
unmyelinated C fibers. Large diameter, densely myelinated Aα/β fibers have the fastest
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conduction of the cutaneous afferents, with speeds > 17 m/s, in rats [6]. While these fibers
are typically unimodal low-threshold mechanoreceptors (LTMRs) transducing propriocep-
tive and mechanosensitive information about the body, a portion of fibers have been iden-
tified with Aβ conduction speeds yet transduce noxious (i.e. painful) stimuli [7]. Thinly
myelinated, smaller diameter Aδ fibers have speeds ranging from 1.8-17 m/s [6], and trans-
duce both noxious and innocuous stimuli from touch, temperature, and pain modalities.
Unmyelinated, small diameter C fibers can be unimodal or polymodal in their transduction
of noxious stimuli, with 0.3-1.3 m/s conduction speeds [6]. Aδ and C fibers transmitting
noxious information from the periphery are called nociceptors. Though nociceptors com-
prise a large portion of fibers with Aδ and C conduction speeds, recent work has identified
the presence of Aδ-LTMR and C-LTMR transmitting non-noxious mechanical information
to the spinal cord [7][8][9][10]. The heterogeneity of sensory fiber functions surpasses the
complexity of conduction speed-based classifications, thus molecular/genetic markers of
afferent subclasses has been the focus of recent work and has enable selective targeting for
imaging and identification using genetically-encoded fluorescent markers and optogenetic
and chemogenetic approaches to control their activity [7].
1.1.2 Dorsal axon tracts
Primary afferents from one dermatome enter the spinal cord through a single segmental
DR. Upon entering the cord, the axon trifurcates with one branch terminating in the dorsal
horn of the spinal segment and the other branches entering a dorsal axon tract, projecting
axon collaterals to the dorsal horn of spinal segments rostral and caudal to the segment of
entry. Short range projections of C fibers and long-range projections of Aδ fibers travel to
other segments via Lissauers tract (LT). While LT consists mostly of C fibers traveling one
segment rostral and caudal to the site of entry, it also contains Aδ collaterals projecting up
to 7 segments rostral [11], and the axons of interneurons. LT laterally borders the dorsal
column (DC) of the medial lemniscus pathway (see Figure 1.2).
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The DC is a collection of ascending afferents transmitting proprioceptive and mechanosen-
sitive information to the dorsal column nuclei of the brainstem; eventually leading to en-
coding and perception at the sensory cortex. While this tract consists mostly of collat-
erals from Aα and Aβ fibers, it also contains visceral C fibers and the axons of neurons
with cell bodies in the dorsal horn called postsynaptic dorsal column tract cells (PSDCs)
[12][13][14][15][16]. PSDCs are mostly located in lumbar and cervical regions of the
spinal cord [13]. These cells receive multi-convergent synaptic inputs from various primary
afferents and account for 30% of cells projecting to the gracile nucleus of the brainstem
[17][13]. Interestingly, anatomical studies suggest that these cells also have intraspinal
axon collaterals located in the same dorsal horn as their cell bodies, indicating a possible
role in altering sensory processing at the spinal cord.
The DC is smallest at sacral segments and gets larger when more axons enter the tract
at lumbar, thoracic, and cervical regions. Branches of Aα/β fibers are shifted medially
in the DC as they ascend and join branches from other spinal segments (see Figure 1.3).
This attributes to the somatotopic organization of the DC in rostral spinal cord regions. In
the cervical cord, the lateral cuneate fascicle transmits information from the neck, arms,
and upper trunk while the medial gracile fascicle sends signals from the lower trunk and
legs [18]. Recent evidence suggests that the receptive field-based somatotopic map model
co-exists, with a modality-specific segregation of ascending DC afferents. In the modality-
based organization, long-range mechanoreceptors project medially in the DC while shorter-
range proprioceptors project laterally [19]. Studies also indicate that as Aα/β fibers ascend
in the dorsal column, their conduction speed decreases with each subsequent collateraliza-
tion of rostral spinal segments [20][21]; suggesting an associated decrease in axon diameter
with each bifurcation.
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Figure 1.2: Schematic of dorsal axon tracts and primary afferent projections.
Primary afferents from a single dermatome have cell bodies that reside in dorsal root ganglion
(DRG). These axons enter the spinal cord via the dorsal root (DR) and trifurcate sending one col-
lateral into the dorsal horn, one collateral rostral, and another on caudal. Both Aδ and C fibers
have collaterals in Lissauers tract (LT). Aαβ fibers travel to the dorsal column nuclei, along side
postsynaptic dorsal column cells (PSDCs), via the neighboring dorsal column (DC).
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Figure 1.3: Somatotopic organization of the dorsal column.
The dorsal column has a somatotopic arrangement that differs, depending on the level of observa-
tion. Sacral afferents (red) compose most of the DC at sacral segments of the spinal cord, but as they
ascend and issue collaterals, the axons are presumed to decrease in diameter and shift more medial
at lumbar (B), thoracic (C), and cervical (D) segments. This phenomenon is conserved across re-
gions of the spinal cord such that at the cervical DC (D), sacral (red) and lumbar (green) afferents
are most medial while thoracic (dark blue) and cervical (light blue) afferents are more lateral.
1.1.3 Dorsal horn terminations
Laminar terminations of afferent presynaptic terminals in the dorsal horn of the spinal cord,
all of which release the excitatory neurotransmitter glutamate, are subtype-specific (see
Figure 1.4). While Aδ and C fibers tend to terminate in the superficial dorsal horn of lam-
ina I-II, Aβ typically terminates in the deeper lamina III-V [22][23]. Synapses with dorsal
horn interneurons serve to integrate and process incoming sensory information, with pro-
jection neurons sending the signals to supraspinal centers of the brain. Projection neurons
transmitting pain and temperature information have axons that travel to the brainstem via
the ventrolateral (anterolateral) tract, commonly referred to as the spinothalamic tract [23].
Nociceptive-specific (NS) projection neurons of lamina I receive excitatory input from Aδ
and C fibers encoding noxious temperature, mechanical, and chemical information from
the periphery [23]. Lamina V wide dynamic range (WDR) neurons receive multimodal,
convergent input from nociceptors and Aβ mechanoreceptors [23].
Many therapeutics intended to induce analgesia (i.e. pain-relief) aim to inhibit noci-
ceptive transmission to or from the spinal cord; with targets including primary afferents
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Figure 1.4: Laminar terminations of primary afferents.
Primary afferents have distinct regions of dorsal horn termination. A) Aδ and C fibers tend to
have monosynaptic connections with interneurons in the superficial dorsal horn (lamina I/II), while
Aβ fibers typically terminate in the deeper dorsal horn (lamina IV/V). B) The signals traveling
via these afferents are sent to brain via nociceptive-specific (NS), wide dynamic range (WDR), or
postsynaptic dorsal column (PSDC) neurons.
(peripheral nerves and DRGs) and the projection neurons of the dorsal horn. In the next
section I review evidence demonstrating the contribution of peripheral and spinal sensory
circuit hyperexcitability to the development and maintenance of pain, with emphasis on
its role in persistent, spontaneous pain. Table 1.1 provides definitions (as it relates to this
dissertation) for key pain-related terminology.
1.2 Persistent Pain: The Role of Peripheral and Spinal Hyperexcitability
Persistent pain is the leading cause of long-term disability, with few available and effective
treatments. Approximately 3% of the world population is plagued with neuropathic pain
resulting from various forms of injury or disease [24]. It is a condition that affects the qual-
ity of life for its sufferers not solely due to the burden of pain, but because it is frequently
comorbid with anxiety, depression, and sleep deprivation.
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Table 1.1: Definitions for pain-related terminology.
Term Definition
nociceptor
pain encoding primary afferents, typically Aδ and
C primary afferents
nociception/nociceptive activity
refers to the transmission of signals from pain
encoding/processing fibers and spinal circuits
sensory (circuit)
for the purpose of this dissertation, refers to primary
afferents and dorsal horn circuitry
hypersensitivity
increased sensitivity to sensory stimuli, can refer to
evoked behavior or neural responses
hyperexcitability
refers to a reduced excitation threshold for sensory
circuits, which can manifest as spontaneous activity
or a greater sensitivity to stimuli
spontaneous a stimulus-independent state of neural activity or pain
evoked a stimulus-dependent state of neural activity or pain
chronic/persistent pain pain that lasts for months or years
neuropathic pain
a chronic/persistent pain state typically occurring
alongside nervous system injury or disease
hyperalgesia increased sensitivity to pain
allodynia perception of pain from typically non-painful stimuli
analgesia relief/depression of pain
1.2.1 Hyperexcitability
Hyperexcitability in neuronal circuits refers to the presence of aberrant spontaneous activ-
ity and/or greater sensitivity to a stimulus-evoked response. Hyperexcitable responses to
stimulation include lower excitation thresholds and the generation of doublet or burst firing
in response to stimulation that would typically elicit a single spike. Sensory circuit hyper-
excitability has been associated with neuronal changes after peripheral and central nervous
system injury or disease, contributing to the emergence of abnormal sensory conditions
including persistent neuropathic pain. Below I summarize clinical and preclinical evidence
implicating sensory hyperexcitability as a driver of persistent spontaneous pain. Though
there are many possible origins of pain in the sensory circuit, the content of this dissertation
focuses on the peripheral and spinal aspects.
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1.2.2 Clinical evidence of peripheral hyperexcitability
Peripheral contributions to neuropathic pain were examined in patients with polyneuropa-
thy, using microneurographya technique permitting examination of single-unit impulse
trains, including those of unmyelinated C-fibers [25]. Peripheral hyperexcitability mani-
fested as reduced receptor threshold (i.e. hypersensitivity), spontaneous activity in C noci-
ceptors, and/or amplified nociceptor stimulus-evoked responses [26][27]. Receptor hyper-
sensitivity is associated with behavioral indications of allodynia, where normally innocuous
stimulation (mechanical or thermal) is perceived as noxious. Spontaneous C fiber activity
demonstrates stimulus-independent activation of nociceptors, an occurrence perceived in
patients as spontaneous burning pain [27]. Hyperalgesia encompasses amplified responses
to noxious stimuli, suggesting an increased sensitivity to pain.
Hyperalgesia resulting from thermal and mechanical stimuli have been linked to re-
duced polymodal C-fiber thresholds [28][27] in patients with chronic pain. While single
impulses are typical responses to electrical stimulation of C fibers [29][30][31] in nor-
mal subjects, double or triple spikes have been observed in painful neuropathy patients
[32][33][27] and this amplified response can coincide with spontaneous activity in the same
nociceptors [33]. Significant differences in mechanoinsensitive C-nociceptors have been
observed in polyneuropathy patients, with those experiencing pain demonstrating a higher
proportion of spontaneously active fibers than those with non-painful neuropathy [34][35].
This evidence, combined with observations that local anesthetic block of peripheral nerves
from painful cutaneous foci abolishes allodynia and spontaneous pain [36][37], implicates
ongoing C fiber input as a persistent driver of nociceptive central processing and subsequent
perceptions of pain.
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1.2.3 Preclinical evidence of sensory hyperexcitability
Early evidence of spinal contributions to evoked hypersensitivity was defined by observa-
tions of activity-dependent plasticity in dorsal horn circuits, frequently referred to as central
sensitization (see Figure 1.5). Experiments demonstrated that repetitive nociceptive stim-
ulation led to a progressive increase in dorsal horn output. This was observed as increases
in spike frequency [38] or amplitudes of dorsal horn field potentials [39][40], phenomena
now referred to as wind up and spinal long-term potentiation (LTP). Electrophysiological
manifestations of central sensitization include reduced thresholds for activation, larger re-
sponses to stimulation, increased receptive field size and persistent stimulus-independent
firing [39][40][41]. These occurrences are said to underlie neuropathic pain conditions like
allodynia, hyperalgesia, and spontaneous pain, observed in patients and animal models.
Peripheral nerve injury models
Models of peripheral nerve injury (PNI), including spinal nerve ligation and chronic con-
striction sciatic injury, have been used to explore both stimulus-evoked and stimulus-independent
manifestations of neuropathic pain. Ipsilateral hind paw sensitivity, manifesting as mechan-
ical allodynia or hyperalgesia, was observed in conjunction with hyperexcitable responses
in dorsal horn neurons [42][43][44]. Studies suggest that stimulus-evoked hyperexcitability
could be caused by factors including WDR spine remodeling [42], injury-induced activa-
tion of substance P receptor (SPR) -expressing neurons [45], or disruption of the glycin-
ergic feed-forward inhibitory circuit [44]. Though peripherally-driven activation of dorsal
horn neurons forms the basis of most observation of central contributions to neuropathic
pain, studies conducted in animals with dorsal root transections suggest that in the absence
of peripheral input, ectopic firing can develop in the dorsal horn neurons and thereby con-
tribute to neuropathic pain [46].
The emergence of stimulus-independent, spontaneous activity in peripheral branches of
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primary afferents has been implicated as a major driver to maladaptive plasticity in spinal
circuits, leading to the development of persistent neuropathic pain. Local nerve blockade
after PNI, prevented the development of spontaneous primary afferent activity and perma-
nently inhibited the develop of hyperalgesia and allodynia [47]. Dorsal root transections,
proximal to the DRG, eliminated observations of centrally conducting spontaneous activ-
ity [48][49]. This was not observed with transections of the peripheral nerve [48][49].
Combined, this evidence identifies primary afferent somata as the source of spontaneous
activity.
Additionally, investigations conducted with models of PNI implicate DRGs associated
with the dermatome of injury, as the driver of subsequent neuropathic pain [50] [49] [51]
[52] [53] [54]. While most studies observed spontaneously active somata of myelinated A
fibers after injury [50][49][51][52][54]; a few studies have also observed hyperexcitability
in C fibers, emerging as spontaneous activity or double-spiking evoked by mechanical stim-
ulation [55][35]. This somatal activity manifests as irregular or burst firing [51][52][53],
and can correspond with enhanced sensitivity to mechanical stimuli, observed electrophys-
iologically [53][52] and behaviorally [50][51][54].
Spinal cord injury models
In spinal cord injury (SCI) models of neuropathic pain, hyperexcitability of dorsal horn
neurons were observed rostral and caudal to level of injury [56]. Lower thresholds and
greater firing frequencies for responses evoked by mechanical and thermal stimuli were
observed in wide dynamic range (WDR) and nociceptive specific (NS) neurons of the dor-
sal horn [56][57]. While upregulated Nav1.3 membrane expression in neurons has been
identified as a potential contributor to these observed responses [57], decreased astrocyte
expression of the GLT1 glutamate transporter has been attributed to increased persistent
activation of dorsal horn neurons, after injury [58].
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In a contusion model of SCI, selective recording of small diameter primary afferent so-
mata (presumed Aδ and C fibers) identified an increased incidence of spontaneously active
and repetitively spiking DRG neurons below the level of injury. This activity corresponded
with behavioral indicators of hypersensitivity to mechanical and thermal stimuli [48][59].
In primary afferent somata, upregulation of Nav1.8 surface expression has been implicated
as a mechanism contributing to the emergence of spontaneous activity [60], while down-
regulation of Kv3.4 surface expression is suggested to underlie multi-spiking phenomena,
after SCI [59].
Figure 1.5: Summary of peripheral and central components of sensory circuit hyperex-
citability.
The evidence presented suggests that neuropathic pain resulting from sensory circuit hyperexcitabil-
ity can have either central or peripheral origins. 1) Hyperexcitability in central circuits can manifest
as wind up, spinal LTP, decreases in recruitment threshold, increases in receptive field size, and
spontaneous activity in dorsal horn neurons. 2) Spontaneous activity in A and C primary afferents
has been identified as a driver of maladaptive plasticity in central circuits. Figure adapted from West
2015[61].
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1.3 Pain Control: Clinical Spinal Cord Stimulation
Pharmacological treatments aim to quell sensory hyperexcitability and subsequent pain
through systemic application of compounds that alter the excitability of target cells. This
can occur via functional activation or inhibition of membrane-associated channels or recep-
tors. The ubiquity of many receptors and channels throughout differing regions of body,
along with the systemic nature of the drug application can lead to off-target side effects.
Some patients are averse to these side effects or experience pain that is resistant to tra-
ditional pharmacological treatment. Thus, electrical neuromodulation has emerged as an
alternative therapeutic.
The spinal cord is a prime target for therapeutics aimed at blocking the transmission of
pain signals, as it is the interface of ascending and descending information to and from the
brain. Spinal cord stimulation (SCS) is a form of electrical neuromodulation that has been
used clinically to inhibit aberrant signaling in cases of refractory pain, for over 40 years.
This is implemented via electrodes inserted into the epidural space and chronically placed
over the dorsal surface of the spinal cord for continuous stimulation. Compared to those
receiving pharmacological treatment alone, patients receiving SCS have reported greater
pain relief and higher quality of life as outcomes of the therapy [62][63]. Details regarding
its clinical implementation are described below, including the parameters utilized and its
efficacy for various pain etiologies.
1.3.1 Stimulation parameters
SCS systems are fully-implantable devices that consist of multi-contact paddle or percu-
taneous arrays positioned in the epidural space and rechargeable pulse generators that can
deliver controlled-voltage or controlled-current pulses [64]. While the enhanced surface
area of paddle electrodes enables larger arrays of electrode contacts and thereby greater
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ability to shape the stimulation field, they require surgical laminectomies for placement.
The advent of percutaneous leads facilitated a reversible surgical procedure with lower as-
sociated morbidity [24]. Epidural placement complicates the goal of neural selectivity, as
the layer of cerebrospinal fluid (CSF) serves as a dampening barrier for applied electric
fields. Thus, technological improvements related to electrode geometry and stimulation
parameters have been implemented with the goal of minimizing off-target stimulation.
Important parameter considerations for the application of SCS include segmental elec-
trode placement, stimulation amplitude, stimulation frequency, and waveform pulse du-
ration; factors that determine the target of stimulation. SCS is commonly used to treat
chronic leg and/or back pain. For this, electrodes are typically placed over the caudal
thoracic cord (T8-T11) in order to activate medial dorsal column fibers ascending from
lumbar segments [64]. Stimulation amplitude and pulse duration are critical parameters
determining if SCS is sub-threshold, therapeutic threshold, or supra-threshold (discom-
fort threshold); along with determining the distribution of activation across multiple der-
matomes [64][65]. For traditional SCS, therapeutic threshold is associated with patients
perception of a tingling/buzzing sensation, or paresthesia. Paresthesia is a sensation said to
result from orthodromic propagation of impulses from dorsal column axons, to the brain. It
is a side-effect of SCS that has been useful for helping to determine appropriate electrode
placement and stimulation parameters (see Figure 1.6) [64]; as concordance of the pares-
thesia focus with pain has been identified as a predictor of relief [24]. Paresthesias have
been deemed necessary, but not sufficient for obtaining lasting pain relief with traditional
SCS [66][24][67][68][69]. Aversion to the paresthesia has resulted in some patients decid-
ing to opt out of the treatment, despite obtaining pain relief [70]. As a result, exploration
of methods to obtain relief with sub-threshold (paresthesia-free) amplitudes have produced
the clinical application of new waveforms and frequencies.
15
Figure 1.6: The focus of paresthesia determines the location of optimal modulation.
SCS at sensory threshold results in the perception of a paresthesia, which can span multiple der-
matomes of the body. Electrode placement and stimulation parameters determine the location of
paresthesia focus. This diagram depicts the effect of changing stimulation pulse duration, with SCS
electrode placement over the caudal thoracic spinal cord. Longer pulse durations result in caudal
shifts of the paresthesia focus. Figure from: Moffitt 2009[64].
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50-150 (a), 15-750 (b), 80± 29 (c), 2-200 (d), 49±16 (e), 39-77 (h),
10000 (h,i), 40-50, (7,9), 40-60 (j)
Amplitude
2-5 V (b), 2.8-5.4V (a), 3±1.5V (c), 3.7±2V (e),
3.6-8.5mA (h), 1.6-3.8 mA (h), 0.05-5 mA (g), 2.36 ± 0.24 mA (i),
2.88±0.15 mA (i), 2.6-11.5 mA (j)
Pulse Duration
(µsec)
150-500 (a), 80-500 (b), 270±79 (c), 350±96 (e),
347-591(h), 30 (h,i), 90-500 (g), 80-200 (j)
(a) Abejon et al 2005[74]
(b) Alo et al 2002[75]
(c) Butyen 2003[76]
(d) North et al 1993[24]
(e) Kumar et al 2006[63]
(f) Alo and Holsheimer 2002[75]




Traditional SCS utilizes tonic stimulation with frequencies ≤ 200 Hz (average 63 ±
54 Hz) [64][24]. Burst waveforms and 10 kHz SCS has been demonstrated to reduce pain
at comparable or superior-levels to traditional SCS, without the paresthesia [71][72][73].
Long-term stability of their effects is still being explored, but these new techniques show
promise for maximizing efficacy and minimizing undesired side effects. Parameters are
manually tuned during surgical placement of the SCS system and effective parameters can
vary greatly between patients. Table 1.2 summarizes SCS parameters previously imple-
mented in clinical settings.
1.3.2 Pain etiologies and efficacy
Over 30,000 stimulators are implanted yearly for patients diagnosed with refractory chronic
leg and back pain from various etiologies including complex regional pain syndrome (CRPS),
failed back surgery syndrome (FBSS), and fibromyalgia[63][2]. Of those etiologies, the
FBSS population is a large proportion of the SCS patient population studied in clinical
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trials [62][77]. FBSS results when a chronic back or leg pain condition fails to resolve
after a patient receives corrective back surgery [77]. Effective treatment is deemed as a
50% or greater reduction in pain scores. On average 62% of FBSS patients obtain effective
relief. Comparable efficacy rates were observed for phantom limb pain (62%) and periph-
eral neuropathy (67%); while greater efficacy rates occurred in ischemic limb pain (77%),
CRPS (83%), and neuralgia (82%) patient populations [62]. Outcomes for clinical trials in
the SCI population have varied greatly. Some studies have indicated no evidence of pain
relief in patients with clinically complete lesions [78], while other have observed higher
success rate in patients with incomplete injuries [79]. When results of all (5) clinical trials
in the SCI population are grouped, 57% of patients receive effective pain relief with SCS,
revealing its potential as a therapeutic for chronic neuropathic pain following incomplete
SCI [62].
Assessing outcomes across etiologies, from 20 years of studies, determined that on
average, only 58% of patients receive effective pain relief using traditional tonic SCS ([2],
see Figure 1.7). The average success rate failed to correlate with study year [2], indicating a
lack of improvement in efficacy despite progress with surgical experience and technological
innovation.
The variable success of SCS in clinical trials is likely the result of improper selection
criteria and neural targeting due to a lack of fundamental understanding of how the tech-
nology works. The next section summarizes suggested mechanisms of action, identified by
preclinical investigations of SCS.
1.4 Spinal Cord Stimulation Mechanisms of Action: Preclinical Demonstrations
The Gate Control Theory of Pain postulates that Aβ fiber input to the spinal cord inhibits
pain encoding through the action of inhibitory interneurons within the dorsal horn [80].
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Figure 1.7: SCS efficacy remained stagnant for 20 years.
This scatter plot depicts the reported mean success rates from clinical SCS studies occurring 1973-
2013, with the average being 58%. Figure from: Zhang 2014[2], adapted from North 1993, Taylor
2013[24][77]
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This theory proposed in 1965 by Melzack and Wall inspired the development of SCS. Since
its conception, pain modulation through excitation of Aβ fibers in the dorsal column and
subsequent inhibition of nociceptive transmission has been the core mechanism accepted
by those developing and utilizing traditional SCS paradigms ([64], see Figure 1.8); despite,
its inability to explain many clinical observations [1][3]. This includes the ability of SCS
to selectively inhibit neuropathic pain and not acute, nociceptive pain [81][82][83][83].
Figure 1.8: Schematic of the presumed SCS mechanism of action
In accordance to gate control theory, it is believed that SCS activates Aβ collaterals in the DC. The
antidromic propagations leads to activation of inhibitory interneurons in the dorsal horn that sup-
presses the transmission of pain signs to the brain. The orthodromic propagation to dorsal column
nuclei is said to underlie the perception of the paresthesia. This theory is unable to explain many
clinical aspects, including that Aβ activation can produce allodynia, an aspect of neuropathic pain
that SCS modulates. Also unexplained is the selectivity of SCS for inhibition of neuropathic, not
nociceptive, pain.
Due to the limitations of working with a clinical population, few clinical studies have
explored other potential underlying mechanisms of actions. As a result, many mechanis-
tic investigations have relied heavily on computational modeling and/or rodent models to
probe the neurobiological basis for analgesia produced by SCS. The insights obtained from
these preclinical studies are described below.
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1.4.1 Computational investigations of recruitment
Most computational modeling studies aim to investigate recruitment of axonal populations
with clinical ranges of SCS. These approaches typically utilize volume conductor models,
cable models of axons, or combine both approaches. Volume conductor/ finite element
models recapitulate the dimensions and electrical conductivity of tissue associated with the
spinal column including the spinal cord (grey and white matter), cerebrospinal fluid, and
vertebral bone [84][85][86][87][88][89][90][91]. These models calculate the distribution
of electric field magnitudes and extracellular voltages generated in the spinal cord, with
epidural placement of SCS electrodes. Cable models of dorsal column and dorsal root ax-
ons partially reproduce the biophysical properties of individual axons or neurons, including
their channel dynamics [86][87][88][89][90][91][92][93]. Input provided by the volume
conductor model (extracellular voltage) permits assessment of excitation of individual or
populations of axons, in response to SCS.
Investigations of traditional SCS suggests that a small population (56 fibers) of large
diameter, myelinated DC axons is recruited with clinical ranges of SCS [87]. The fibers
activated at therapeutic threshold, with electrodes placed at a caudal thoracic (T10/T11)
segment, encompass fibers ascending from multiple dermatomes [87][84][94]; with the
possibility of paresthesia concordance and subsequent pain relief resulting from activation
of a single fiber from the target dermatome [87]. While one study suggested that DR ax-
ons have a lower threshold for activation, due to their curvature and angle at the dorsal
root entry zone [89], subsequent studies suggest that supra-threshold (discomfort thresh-
old) SCS is associated with recruited of Aβ fibers from dorsal roots [87][84]. Differing
results have been reported from investigations of recruitment with 10 kHz SCS. One study
suggests that paresthesia-free SCS is obtained by blocking impulses generated in large di-
ameter, myelinated DC fibers; preventing transmission of the paresthesia signal to the brain
[90]. Another study finds that amplitudes necessary to activate and/or block conduction in
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myelinated DC fibers are outside the range of amplitudes used clinically [91].
While computational models are useful tools for preliminary assessments of recruit-
ment, the strengths of their claims largely depend on experimental validation. Clinical
studies [84][65] have enabled low-resolution assessment of SCS recruitment but has pro-
vided limited information regarding the analgesic actions engaged in the dorsal horn. Thus,
animal models of pain have been used to probe underlying mechanisms leading to SCS-
induced analgesia.
1.4.2 Animal investigations of mechanism
Exploration of SCS mechanisms of action frequently employ rodent models of peripheral
nerve injury to investigate activation of native antinociceptive spinal and/or supraspinal cir-
cuitry. This typically consists of behavioral assessments during awake-behaving conditions
or in vivo electrophysiological assessments during anesthetized conditions. In these inves-
tigations, stimulation amplitude is determined by identifying the motor threshold (MoT),
the amplitude of SCS a reflexive muscle contraction, for each subject. SCS-induced anal-
gesia has been explored using amplitudes associated with 50-90% of MoT and 200 µs pulse
durations, with traditional frequencies of SCS [95] [96] [97] [98] [99] [100] [101] [102]
[103] [104] [105] [106] [107] [108] [109] [110] [111].
Gate control presumes the activation Aα/β fibers that serve as a switch between open
(transmission) and closed (block) for supraspinal propagation of nociceptive signals. Mod-
eling and animal studies suggests that myelinated dorsal column afferents are recruited
by SCS. While an early study suggested the population contributing to analgesia was Aδ
fibers [112], a later study found that the amplitude used to alleviate mechanical hyper-
sensitivity was lower than the Aα/β fiber threshold [113]. This suggests that subsequent
SCS relief occurs via supra- or sub- primary afferent recruitment thresholds, which is in
22
conflict with the assumptions of gate control. The role of spinal GABA, an inhibitory
neurotransmitter, has also been explored. Mononeuropathic animals exhibited tactile allo-
dynia, along with decreased extracellular GABA in the dorsal horn [111]. Animals that
obtained alleviation of allodynia with SCS (responders) exhibited an increase in GABA
levels, in response to stimulation [111]. Non-responders could obtain similar alleviation
when SCS was combined with intrathecal administration of GABA or an GABAB agonist
[109]. While intrathecal administration of a GABAA antagonist has been demonstrated to
have no effect on threshold augmentation generated by SCS [109]; another study observed
increased spontaneous and evoked activity in spinal projection neurons, shifting toward
the production of enhanced excitatory responses and reduced inhibitory responses to SCS
[114]. Combined, this confirms the importance of inhibitory interneurons for SCS-induced
analgesia, as predicted by gate control. It also suggests that persistent neuropathic pain and
ineffective SCS may be the result of insufficient inhibitory drive in the spinal cord. Gate
control also predicts gating would only persist for the duration of A fiber stimulation. But
an additional observation suggests that the suppressive effects on spontaneous and evoked
activity of projection neurons outlasts the SCS stimulation period (˜10 mins)[110]. Other
studies indicate that SCS possibly attenuates neuropathic pain by decreasing activation
of glial cells [96] and pathways regulating proinflammatory cytokines [107] in the dorsal
spinal cord.
Investigations of supraspinal contributions suggests that both spinal and descending
brainstem mechanisms work to suppress dorsal horn nociceptive transmission during SCS
[100][101][108] [99][105]. Specifically, descending serotonergic pathways appear to have
a prominent role in SCS modulation. Descending serotonergic collaterals travel to the
spinal cord via the dorsal lateral funiculus (DLF). Bilateral lesion of the DLF prior to
SCS reduced its inhibitory effects by ˜50% [105]. Additionally, SCS Non-responders be-
came responders when stimulation was combined with sub-effective doses of 5-HT [100].
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Intrathecal application of various 5-HT receptor agonists or antagonists prior to SCS, re-
vealed that 5-HT2A, 5-HT3, and 5-HT4 activation contributes to observed attenuation in
mechanical hypersensitivity [101]. Further, it indicated that the previously established link
between serotonin and GABAergic activity [100] may be facilitated by 5-HT3 receptors on
inhibitory interneurons [101]. While the neuronal source of the descending serotonergic
modulation has not been identified, electrophysiological recording indicated changes in the
activity of cells located in the locus coeruleus [97] and the rostroventromedial medulla [98]
during SCS.
Mechanisms underlying burst and high frequency (1-10 kHz) SCS has also been ex-
plored, but still remains unclear. Consensus across these investigations suggests that while
burst and high frequency SCS produces attenuated mechanical hypersensitivity comparable
to traditional SCS—possibly resulting from reduced Aα/β fiber input [102], the underlying
mechanisms are likely different [102][103][115][116] [117][106][104]. Burst stimulation
appears to reduce neuronal firing, but this occurs without the increase in GABAergic ac-
tivity observed with traditional SCS [106]. High frequency SCS is effective at amplitudes
subthreshold to paresthesia induction. Evidence indicates that this stimulation does not ac-
tivate the gracile nucleus of the brainstem like traditional SCS, suggesting that its primary
actions are likely in the dorsal horn [103]. The lack of brain stem activation contributes
to the absence of a perceived paresthesia, though it is not due to conduction block of as-
cending fibers in the dorsal column [116]. While induced reduction in neuronal excitability
has been proposed as a potential spinal mechanism of high frequency SCS, studies deter-
mined that it does not inhibit wind up induced by repetitive C fiber activation [102] or
hyperpolarize dorsal horn neurons [117].
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1.5 Summary and Goals
I have presented the body of work that establishes the importance of sensory circuitry hy-
perexcitability in the development and maintenance of persistent neuropathic pain, after
nervous system injury. SCS is a therapeutic used clinically to modulate pain resistant to
pharmacological treatment; but its efficacy has been stagnant, despite technological ad-
vances and application of new stimulation paradigms. An unclear understanding of the
neurobiological basis for SCS-induced analgesia has been identified as a key contributor to
the lack of improvement in success rates. Computational models have provided the most
detailed assessment of axonal recruitment, but the theoretical results are rarely validated
with experimental observations. Experimental studies with rodent models of neuropathic
pain typically assess SCS modulation with amplitudes associated with MoT. The relation-
ship between MoT and paresthesia/recruitment in humans in unclear. This presents the
possibility that the experimental studies employ stimulation parameters that are not prop-
erly scaled for clinically-analogous investigations in animal models. Also, there is a dearth
of evidence identifying the role of SCS in modulating spontaneous pain, despite being a
key feature of its clinical effects. Most studies behaviorally or electrophysiologically as-
sess modulation of stimulus-evoked hypersensitivity. This is likely the result of insufficient
methods for assessing behavioral indicators of spontaneous pain and an inability to estab-
lish links between spontaneous hyperexcitability in sensory circuits to such behavioral met-
rics. Here, I developed and utilized ex vivo adult mouse preparations to investigate markers
of persistent pain and perform detailed electrophysiological studies of SCS recruitment and
modulation. This dissertation sought to (a) identify the relationship between spontaneous
sensory hyperexcitability and physio-behavioral indices of spontaneous pain (Chapter 2),
(b) characterize axonal recruitment using clinically-analogous SCS (Chapter 3), and (c)
characterize a pharmacological model of spontaneous pain and assess modulation of spon-
taneous activity with SCS (Chapter 4). In the final chapter I discuss implications of this
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work and suggest future research directions for continued advancement of the field.
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CHAPTER 2
PERIPHERAL HYPEREXCITABILITY AND PHYSIO-BEHAVIORAL INDICES
OF PAIN
2.1 Abstract
Spinal cord injury (SCI) commonly leads to the development of neuropathic pain in re-
gions below the site of injury as well as impaired sleep and respiratory function. Animal
studies suggest SCI-induced neuropathic pain associates with ongoing spontaneous activ-
ity in pain encoding sensory fibers (peripheral hyperexcitability), but whether spontaneous
pain links with impaired sleep and other pathophysiology is unknown. Here, we use a
mouse T10 contusion SCI, known to develop mechanical hypersensitivity, to investigate
whether there are emerging physio-behavioral changes that would be indicative of ongoing
spontaneous pain. We leveraged non-contact electric field sensor technologies, validated
to accurately record respiration and sleep architecture, to assess whether emergent changes
seen after SCI in sleep and respiration are associated with electrophysiological evidence
of ongoing spontaneous activity in sensory fibers. To achieve this, I developed an ex vivo
preparation to record from lumbar L1-L6 dorsal root ganglia (DRG) in situ. I compared
recordings of spontaneous activity six weeks after sham or T10 SCI. After SCI, there was
greater spontaneous afferent activity and this correlated well with increased hindpaw me-
chanical sensitivity, increased respiratory rate variability, and increased sleep fragmenta-
tion. Observed correlations between spontaneous afferent activity with evoked mechanical
sensitivity and fragmented sleep support an important interplay between sleep and pain
after SCI. Together, these results highlight the utility of spontaneous peripheral hyperex-
citability, alongside sleep segmentation, and respiratory rate variability as potential indices
of stimulus-independent neuropathic pain.
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2.2 Introduction
Neuropathic pain is a condition that develops following peripheral or central nervous sys-
tem injury, resulting from trauma or disease. Heterogeneity in the etiologies and presenta-
tions of pain contribute to difficulties finding generalized treatment options. The persistent,
stimulus-independent nature of neuropathic spontaneous pain enhances its negative impact
on quality of life for its sufferers, highlighting the need to accurately assess and treat this
chronic condition. As a result, several models of neuropathic pain have developed to help
understand the neurobiological mechanisms and explore new treatment strategies, yet ex-
perimental assessment tools are optimized for exploring stimulus-evoked neuropathic pain
such as allodynia and hyperalgesia [42][43][44]. This is in part due to challenges in iden-
tifying and quantifying metrics of chronic, spontaneous pain.
In an effort to identify and quantify spontaneous pain states, studies have uncovered
functional changes in central and peripheral neurons. There is increasing evidence that
spontaneous primary afferent activity represents one initiation site and chronic driver of
maladaptive sensory processing, leading to neuropathic pain perception. Spontaneous ac-
tivity in both A and C fibers has also been observed in various neuropathic pain states
[50] [49] [51] [52] [54]. Key studies conducted in rodent contusion models of spinal cord
injury (SCI) revealed potential links between stimulus-evoked hypersensitivity (hyperalge-
sia/allodynia) and the incidence of spontaneous firing in cell bodies of primary afferents
below the level of injury [48] [59] [118] [60]. These studies predominantly assessed spon-
taneous activity from C fiber dorsal root ganglia (DRG) neurons, and relied largely on
observations of increased incidence in spontaneous activity following DRG dissociation.
A caveat using this approach is that the method of DRG dissociation itself may induce
hyperexcitability, including increased spontaneous firing that mirrors the effects seen after
chronic compression of DRGs [119]. In summary, there is need for additional studies in
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more intact circuitry to identify and causally link spontaneous DRG activity after SCI as a
metric of an abnormal sensory state.
In addition to identifying the drivers of spontaneous pain, it is important to understand
the symptomatic manifestations and how they relate electrophysiological changes. In ro-
dent models, the presence of pain is often determined granularly through visual observa-
tion of animal grooming and social habits. Pain-related sensitivity is commonly quantified
through mechanical or thermal stimulation of fore or hindlimbs, though these methods rep-
resent behavioral stressors which may significantly alter the outcome [43] [44] [48] [59]
[118] [60]. Moreover, such tests measure alterations in reflex response sensitivity and do
not necessarily translate into supraspinal encoding of the affective dimension of pain. This
is particularly a problem in studies on SCI pain where ascending pain pathways may have
been severed. The implementation of a conditioned place preference (CPP) paradigm–that
uses analgesic administration to positively reinforce location with pain relief, introduces
the possibility of assessing ongoing spontaneous pain while also clearly testing for the cog-
nitive affective/motivational dimension of pain [120] [121] [122] [60]. A weakness is re-
liance on the selectivity of drugs to produce analgesia without confounding side effects. We
considered an alternative approach to quantify persistent spontaneous pain in an attempt to
address limitations of existing behavioral assays. We explored the use of noninvasive meth-
ods to assess other behaviors known to be affected by spontaneous pain, including sleep
and respiration. These measures are well-suited to studies on SCI-induced pain because
SCI has a significant impact on sleep quality [123] [124] [125] [126] and respiration [127]
[128] [129] without impairing the neural pathways controlling these behaviors, and these
changes may be related to the presence of pain.
Here, we explore the relationship between spontaneous primary afferent activity (pe-
ripheral hyperexcitability) and physio-behavioral indices (sleep and respiration) that may
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concomitantly shift during the transition to neuropathic pain, after SCI. In the thoracic
contusion SCI model of neuropathic pain, we examine metrics associated with sleep archi-
tecture and respiratory function, using non-invasive electric field sensors. We also com-
pare these behavioral outcomes to established mechanical sensitivity testing, along with
post-mortem observations of spontaneous activity in whole DRGs, below the level of in-
jury. Results from these studies link peripheral hyperexcitability to greater segmentation
of sleep and erratic breathing, identifying these metrics as potential stimulus-independent
indicators of chronic spontaneous pain.
Parts of this work have been presented previously in abstract form [130].
2.3 Methods
2.3.1 Animals
All procedures were approved by the Emory University Institutional Animal Care and Use
Committee. Adult C57/Bl6 mice (n = 18, female) were pair housed in home cages un-
der standard 12:12 hour light-dark cycles with ad libitum food and water. Animals were
acclimated to their pair housing for several weeks prior to the start of baseline testing.
2.3.2 Animal surgeries
SCI was induced via moderate contusion of the T10 spinal cord segment [131]. First,
mice (n=13, postnatal day 205) were prepared for aseptic surgery and deeply anesthetized
with 2-3% isoflurane. A midline skin incision was made and the muscle and fascia were
dissected. A dorsal laminectomy exposed the spinal cord at T8-T10. At this point, muscular
incisions in six animals were closed using surgical glue (Vetbond) and skin was closed with
wound clips (size and company) to simulate the sham control group (Sham Group n=6).
Prior to wound closing of the remaining 7 animals, a moderate contusion SCI was induced
at the dorsal surface of the T9/10 spinal cord with the Infinite Horizon impactor (IH-400,
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Precision Systems and Instrumentations), at 50 kdynes (SCI Group n=7). All mice received
post-operative pain relief (2 mg/kg meloxicam, subcutaneous injection, daily for 48 hours),
antibiotics (2.5 mg/kg Baytril, subcutaneous injection, daily for seven days), supplemental
hydration (0.5 ml sterile saline, i.p. daily for 48 hours), and bladder expression twice daily
until each animal was able to void independently.
2.3.3 Physio-behavioral monitoring
Home cage exteriors were instrumented with electric field (EF) sensors (Plessey Semicon-
ductors, PS25251, 1 cm2, +/-5V, 1 kHz sampling) able to passively translate disruptions
of the local electric field caused by movement into a voltage trace[132][133][134]. EF
sensors were connected to a custom filter (12 Hz lowpass) and amplifier. Data were col-
lected using Digidata and pClamp software (Axon Digidata 1440a, Molecular Devices,
USA), and analyzed in Spike2 (Cambridge Electronic Design, UK) and MATLAB. The
EF sensors can measure animal motion with high resolution from outside the home-cage
[132][133][134]. Moreover, these EF sensors are able to reliably measure extremely small
mouse motions with great sensitivity, allowing them to detect respiratory-related move-
ment, validated against whole body plethysmography, when the animal is at rest [132].
Furthermore, EF sensors were recently validated against electroencephalogram and elec-
tromyogram to successfully quantify three stages of arousal: wake, rapid eye movement
(REM) sleep, and non-REM sleep non-invasively from outside the animal’s home cage
[134].
Four EF sensors were attached to the exterior of the animals’ home cage facing inward
(see Figure 2.1A). During active recording, the home cage was temporarily divided into
two chambers, with one animal and two EF sensors in each, by an electrically shielded
insert that allows visual, olfactory, and thermal interactions between the two animals. Each
chamber was outfitted with individual food hoppers and water bottles. Petri dishes (60 mm)
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were placed in one corner of each chamber as a recommended nesting location. Animals
were acclimated to the temporary division for several days prior to baseline recordings.
Home cage activity, resting respiration features, and sleep architecture was recorded for
12 hours during the dark cycle three times prior to spinal cord injury (baseline) and twice
weekly afterwards for 6 weeks.
2.3.4 Sleep analysis
Sleep was analyzed twice weekly during the 12-hour dark cycle (6 pm-6 am) which is the
animal active period. Though mice are nocturnal, they still sleep an average of 20-30%
of the dark cycle and this period was chosen to minimize environmental sleep disruptions
that would alter normal sleep habits. Described previously [134], 3-state sleep architecture
(wake, non-REM sleep, and REM sleep) is calculated through changes in animal movement
and respiration.
Sleep was assessed cumulatively (non-REM and REM sleep combined) and as individ-
ual non-REM and REM sleep during the 12-hour dark cycle (active period). The outcomes
discussed below compare the median sleep event duration, the average number of sleep
events, and the average number of brief arousals between treatment groups over the 12
hour dark cycle (ee Figure 2.1B, 2.1D). The number of sleep events is normalized to how
many hours an animal slept, with more events denoted more fragmented sleep. The related
metric of brief arousals quantifies the average number of short wake events (<60 secs)
occurring per hour of sleeping and differentiates typical arousals that naturally happen at
the conclusion of REM from abnormally brief arousals that disrupt the natural cycle of
non-REM and REM sleep. A greater number of sleep events and brief arousals suggests
more segmented, disrupted sleep, which may indicate lower quality sleep. Though animals
were recorded twice weekly, a representative weekly value was calculated for each animal
by first calculating nightly means then averaging the two nights per week together. Only
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baseline (pre-SCI or Sham procedure) and week 6 post-injury data are discussed here as
the objective is to associate behavior with terminal electrophysiological metrics at week 6.
2.3.5 Respiration analysis
Respiration is detected by the EF sensors as a cyclic voltage trace representing the breath-
ing cycle (see Figure 2.1B). Respiration features were measured only when the animal was
at rest during non-REM sleep or when the animal was quietly resting prior to sleep. Res-
piration cannot be reliably measured when the animal is active because the voltage trace
deflections caused by the breathing cycle are overshadowed by the larger motor movements.
Average resting respiratory rate (RR) was determined by averaging the instantaneous fre-
quencies of each breathing cycle using the corresponding peak of the voltage trace during
a non-REM sleeping event. Average RR represents the number of breaths the mouse will
take in a second. RR variability (RRV) is the standard deviation of these instantaneous
frequencies within a single non-REM sleeping event and represents how erratically an an-
imal breathes in one second. Low RRV (<0.3 Hz) indicates consistent breathing while
high RRV (>0.3 Hz, defined as more than 2 standard deviations away from healthy animal
RRV) indicates erratic breathing. All the RR and RRV calculations were performed using
a custom MATLAB script that filters the voltage trace (0.1 Hz HP 4th order Butterworth,
10 Hz LP 4th order Butterworth), then finds the periods when the animals are in the resting
state, and calculates the breathing cycle peaks, instantaneous frequencies, RR, and RRV.
Just as with sleep measures described above, nightly RR and RRV means were averaged to
create a baseline and week 6 representative value for each animal.
2.3.6 Mechanical sensitivity
Mechanical sensitivity was measured using Chaplan’s up-down protocol for von Frey fila-
ments [135]. Briefly, animals were acclimated to the von Frey filaments (1.65, 2.44, 2.83,
3.22*starting filament, 3.61, 3.84, 4.17, and 4.31 sizes; correlating to 0.008,0.04, 0.07,
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Figure 2.1: Methodology for non-invasive monitoring of animal sleep and respiration.
A) Home cage instrumentation for electric field sensing. A total of 4 individual EF sensor is were
used per cage, with 2 dedicated to each animal. B) Example recording of breathing with electric
field sensor along with equations for the calculation of sleep and respiration metrics. C) Measure
of behavioral metrics were taken weekly until the terminal electrophysiology experiments. Here we
only report on the measures at baseline, and at week 6 in order to compare electrophysiology and
behavior. D) Example spectrogram (top panel) and overlaid hypnogram (white trace) obtained from
electric field sensor recording (bottom panel) for quantification of sleep events.
0.16* starting force, 0.4, 0.6, 1.4, and 2.0 grams), cages, and mesh floor for several days
prior to testing. Mechanical sensitivity was assessed in both hind paws three times prior
to surgery and once weekly afterwards for 6 weeks. The 50% paw withdrawal threshold
(PWT) was quantified for both treatment groups. This metric is defined as the stimulus in-
tensity (in grams) required to produce a withdrawal response 50% of the instances when the
tip is applied to the plantar surface of the paw (i.e. the animal is equally likely to tolerate or
withdraw from that stimulus). This behavioral test is frequently used to infer the emergence
of pain presenting as mechanical allodynia and the 50% PWT has been shown to shift in
many disease and injury models that include pain. Lower PWTs associate with heightened
mechanical sensitivity and may suggest the emergence of allodynia as part of the neuro-
pathic pain state after neural injury. Single-animal values were obtained by averaging the
50% PWT for both hind paws at baseline and week 6 post-injury.
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2.3.7 Isolation of multisegmental DRGs
Following 6 weeks of postoperative behavioral testing, animals (postnatal day 247-267)
were lightly anesthetized in an isoflurane chamber then given an intraperitoneal injection
of ketamine (100mg/kg) and xylazine (10mg/kg). Prior to decapitation, the dorsal skin
from the neck to the base of the tail was removed and the region over the spinal column
was covered with ice until there was a noticeable slowing of the respiration rate. Next,
the spinal column and surrounding tissue were isolated and placed in a dish containing
ice-cold, oxygenated (95% O2 / 5% CO2) low-Ca2+ artificial cerebral spinal fluid (aCSF)
composed of (in mM): NaCl 128, KCl 1.9, MgSO4 13.3, CaCl2 1.1, KH2PO4 1.2, glucose
10, NaHCO3 26. Both a complete laminectomy and vertebrectomy were preformed to
expose the spinal cord and DRGs from segments C8 through S1. Dorsal and ventral roots
from each spinal nerve were cut to isolate the DRGs. The isolated tissue was equilibrated to
room temperature for 1 hour, then pinned at the dorsal roots in a Sylgaard-lined recording
chamber while superfused with an oxygenated aCSF containing (in mM): NaCl 128, KCl
1.9, MgSO4 1.3, CaCl2 2.4, KH2PO4 1.2, glucose 10, NaHCO3 26, at ˜40ml/minute. All
experiments were undertaken at room temperature.
2.3.8 Extracellular DRG recordings
Prior to recording, connective tissue surrounding the DRGs (dura and pia) were removed to
enable sufficient access to cell bodies. Glass suction electrodes (200-250 µm tip diameter)
were positioned below the level of injury on lumbar (L1-L6) DRGs and recorded activity
(silent or spontaneous) for a minimum of 25 seconds (see Figure 2.2). In all animals,
every undamaged lumbar DRG (viable) that remained following isolation was recorded,
with the maximum number reaching 11. The number of viable DRGs was predominantly
a function of the isolation precision. All recorded data were digitized at 50 kHz (Digidata
1322A 16 Bit DAQ, Molecular Devices, U.S.A.) with pClamp acquisition software (v. 10.7
Molecular Devices). Recorded signals were amplified (5000x) and low-pass filtered at 3
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kHz using in-house amplifiers. Post-hoc, data was high-pass filtered at 5Hz, to eliminate
baseline drifts in the recordings.
Figure 2.2: Methodology for electrophysiology for isolated DRG preparation
Ai) A schematic of the isolated DRG preparation. Following exposure of the spinal cord and pe-
ripheral aspects of primary afferents (DRG, dorsal root, spinal nerve) from C8-S1 segments, the
dorsal roots (DRs) and ventral roots (VRs) were cut at each segment, leaving only a section of the
DRs with the attached DRGs and the surrounding ribs and musculature (not shown). Aii) Example
recordings of spontaneous activity in the lumbar L3 DRG from the SCI (red) and L1 DRG from
the Sham (black) populations. Displayed is a single sweep from maximally active DRGs from 2
different animals. Single units marked with * are expanded in the inset (scale bars are 2 ms and 10
µV).
2.3.9 Data analysis
Electrophysiological data and behavioral data were analyzed independently, by two differ-
ent experimenters. Average values reported in results represent the mean ±standard devia-
tion. Post-hoc threshold event detection with Clampfit analysis software (v 10.7 Molecular
Devices) enabled identification of spike counts. All software-identified spikes were manu-
ally examined to ensure that individual spikes fit the durations expected for single units (>1
ms). Counts of spontaneously active (SA) and silent DRGs were determined manually. SA
DRGs were identified as DRGs producing >1 spike within 25 secs. Maximal DRG firing
frequency was determined by calculating the average number of spikes occurring within 5
secs bins of the overall recording time. This was determined for a single DRG from each
animal, where maximal firing was observed. Incidences of SA DRGs were determined by
calculating the percentage of DRGs with observable spontaneous activity, relative to the to-
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tal number of DRGs recorded within an animal. Due to the non-uniform sampling of DRGs
from each animal, individual incidence values were weighted relative to the total number
of possible DRG observations (bilateral DRGs for L1-L6 = 12). This was accomplished
by multiplying each value by (# of sampled DRGs / 12), enabling greater weighting of
incidences obtained in animals where a larger proportion of the total possible DRGs were
observed. In all data presented, the number of animals sampled for analysis is represented
by the noted n/12 value.
Statistical differences in behavioral metrics of sleep, respiratory, and sensory function
were determined using 2-Way ANOVA, with Sidak’s multiple comparison’s test (α =0.05)
for both treatment groups, at baseline and postoperative week 6. Analysis of differences in
DRG firing frequencies and weighted incidences of SA DRGs between treatment groups
was performed using the two-tailed Mann-Whitney test. For correlation analysis, we quan-
tified the residual change from baseline to week 6 for PWT, sleep metrics, and RRV. As-
sociations between behavioral metrics (postoperative week 6) and post-mortem electro-
physiology were estimated using Pearson correlation analysis. All statistical analysis was
performed in Prism (v7).
2.4 Results
2.4.1 Sleep becomes fragmented after SCI
Sleep architecture was assessed at baseline and week 6, for both treatment groups. Though
Sham group animals slept more total time at week 6 relative to their baseline (p <0.05),
total sleep time did not change in SCI animals, nor were there any significant changes in
non-REM and REM sleep time for both SCI and Sham group animals (Table 2.1). Baseline
values between groups (for all metrics) were not significantly different (p >0.6). For SCI
sleep event duration (Figure 2.3Ai), number of sleep events (Figure 2.3Aii), and number
of brief arousals (Figure 3Aiii), there was a significant difference from baseline (p<0.001)
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Table 2.1: Summary of sleep architecture results.
Values represent the mean ±STD.
**p<0.001, ****p<0.0001 for differences between Sham and SCI groups at week 6
# p<0.05, ## p<0.001, ### p<0.0001 for differences between baseline and week 6 for
each group
Sham (n=6) SCI (n=7)
baseline week 6 baseline week 6
Sleep Event Duration (s) 284.2 ±42.6 307.0±78.2 285.7±72.9 126.4±24.3∗∗∗##
Number of Sleep Events 10.4±2.4 10.6 ±1.0 8.9±1.8 30.6±4.8∗∗∗∗###
Number of Brief Arousals 4.5±2.2 4.1±1.2 3.3±1.1 20.3±2.9∗∗∗∗###
Total Time Spent Asleep
(% of 12 Hour Dark Cycle) 17.9±9.6 29.6±8.0# 19.2±6.7 19.9 ±7.5
Total Time Spent in
Non-REM Sleep
(% of Time Spent Asleep)
87.3±2.7 87.4±3.6 88.8±1.3 86.9±2.6
Total Time Spent in
REM Sleep
(% of Time Spent Asleep)
12.1±5.9 12.1±5.6 11.2±3.1 12.2 ±2.9
and significant differences when compared to the Sham group at week 6 (p <0.001). The
results for sleep architecture assessment are summarized in Table 2.1. Analysis of lin-
ear associations between these metrics revealed a positive correlation between number of
brief arousals and number of sleep events (r = 0.84, p <0.05) in the SCI group, but no
correlations between any of the metrics for the Sham group, or across groups.
2.4.2 Respiration becomes more erratic after SCI
The average resting RR at baseline was similar for both groups and unchanged 6 weeks after
SCI or Sham surgery (p >0.5, Figure 2.3Bi). However; there was a significant increase
in RRV for the SCI group at week 6, relative to baseline (p<0.0001). Also, the average
RRV for Sham and SCI were significantly different at week 6 (p<0.0001, Figure 2.3Bii).
Results are summarized in Table 2.2.
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Table 2.2: Summary of respiration results.
Values represent the mean ±STD.
****p<0.0001 for differences between Sham and SCI groups at week 6.
### p<0.0001 for differences between baseline and week 6 for the SCI group
Sham (n =6) SCI (n=7)
baseline week 6 baseline week 6
Average RR (Hz) 3.3±0.3 3.3±0.2 3.6±0.6 3.5±0.5
RRV (Hz) 0.2±0.02 0.2±0.03 0.2±0.03 0.4±0.1∗∗∗∗###
2.4.3 SCI results in hindpaw hypersensitivity
Mechanical sensitivity was assessed prior to surgery (baseline) and postoperative weeks
1-6 for Sham (n = 6) and SCI (n = 7) groups to confirm that our injury model exhibits
the expected time course in the development of mechanical hypersensitivity. Relative to
baseline, SCI animals exhibited heightened mechanical sensitivity at all time points ex-
cept week 1 (p <0.005). Comparison of 50% PWT between treatment groups revealed
significantly heighted mechanical sensitivity in SCI animal, when compared to Sham, that
persisted after week 2 (p <0.005, Figure 2.3C). Average 50% PWTs at week 6 for Sham
and SCI were 2.2 ±0.3 g and 0.6 ±0.2 g, respectively.
2.4.4 Spontaneously active DRGs: stimulus-independent indicator of peripheral hyperexcitability
To assess below-level spontaneous primary afferent activity, silent and spontaneously active
(SA) L1-L6 DRGs were recorded bilaterally from SCI (n =7) and Sham (n = 6) popula-
tions 6 weeks after SCI or Sham injury. Compared to Sham (0.6 ±0.3 Hz), SCI animals
exhibited greater spontaneous activity (2.5 ±1.2 Hz), as characterized by the maximal DRG
firing frequency (p <0.005, Figure 2.3Di). The weighted incidence of SA DRGs in the
SCI population (29.8 ±16.5%) was significantly greater than Sham (12.5 ±4.6%, p <0.5,
Figure 2.3Dii). Overall, these results suggest that greater spontaneous activity/peripheral
hyperexcitability emerges after SCI.
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Figure 2.3: Features of sleep, respiratory, and sensory function are altered after SCI.
A) The median sleep event duration (i), number of sleep events/hour asleep (ii), and number of brief
arousals/hour asleep (iii) during a 12-hour dark cycle is significantly different when comparing SCI
vs Sham at postoperative week 6 (w6); and baseline (b) vs week 6 (w6) in the SCI group B) Average
respiratory rate appears unaffected by SCI (i), while respiratory rate variability differs significantly
when comparing SCI vs Sham at postoperative week 6 (w6); and baseline (b) vs week 6 (w6) in the
SCI group (ii). C) Trends in paw withdrawal threshold (PWT) progress as expected over 6 weeks of
von Frey behavioral testing. Beginning at postoperative week 2, significant differences are observed
in 50% PWT for the SCI group, when compared to Sham. Graph depicts the mean values ±standard
deviation. D) The maximal observed firing frequency (i) and weighted incidence (ii) of SA lumbar
DRGs in the SCI group are significantly greater than that of the Sham group. For panels A, B and
D, the data are presented as violin plots where each data point is the mean value for each animal
sampled, the grey line is the mean value for the population, and width providing relative probability
density distribution of the sample. SCI (n=7), Sham (n=5). The p-values are denoted throughout,
as follows: SCI vs Sham at week 6- *p<0.05, ** p<0.005, *** p<0.0005, **** p<0.0001; baseline
vs week 6 in the SCI group- # p<0.001, ##p<0.0001
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2.4.5 After SCI, the incidence of spontaneously active DRGs correlate with the change
in PWT
Peripheral hyperexcitability can manifest as exaggerated evoked responses or enhanced
stimulus-independent, spontaneous activity. To assess the association between different as-
pects of peripheral hyperexcitability, correlation analysis for metrics of evoked and stimulus-
independent (firing frequency and incidence of SA DRGs) sensory activity was performed.
Across groups there was no correlation between these evoked or spontaneous (p>0.05).
However, when looking at each animal’s week 6 PWT change from its respective base-
line value (residuals), DRG incidence was correlated with the decrease in PWT between
baseline and week 6 in the SCI group (r = -0.82, p<0.05, Figure 2.4A). There was no
correlation between these metrics, for the sham group.
2.4.6 Indices of spontaneous peripheral hyperexcitability correlate with functional shifts
in sleep and respiration
To assess linear associations between the emergent sleep and respiration changes with indi-
cators of peripheral hyperexcitability, we performed correlation analysis with sleep metrics
(sleep duration, number of sleep events, and number brief arousals) and RRV. For sleep
metrics and RRV, we quantified the residual change from baseline to week 6. There were
no correlations across groups or in the Sham group, for any of the residualized metrics.
However, in the SCI group, DRG incidence correlated with the residual number of sleep
events between baseline and week 6 (r = 0.78, p<0.05, Figure 2.4B) and firing frequency
correlated with the residual change in RRV (r=0.9, p<0.01, Figure 2.4C). No metrics of
stimulus-independent hyperexcitability correlated with residual changes in sleep duration
or number of brief arousals in SCI animals. Nor did the change in PWT correlate with the
residualized RRV or sleep metrics in SCI animals.
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Figure 2.4: Spontaneous hyperexcitability metrics correlate with changes in evoked hyper-
excitability, respiration, and sleep after SCI.
A: Incidence of SA DRGs in the SCI group has a negative correlation with the change in 50%
PWT threshold (compared to baseline), measured at postoperative week 6. B: In the SCI group, the
change in the number of sleep events at week 6 (compared to baseline) has a positive correlation
with the incidence of below-level SA DRGs. C: Maximal firing frequency has a positive correlation
with the change in respiration rate variability (compared to baseline) at week 6. Linear associations
between metrics were determined by Pearson correlation and regression analysis. Each data point
is a representative value for each animal sampled. SCI (n=7)
2.5 Discussion
The relationship between manifestations of pain and concomitant behaviors is highly con-
voluted and challenging to unravel. In a contusion model of neuropathic pain, we found
that dysfunction in respiration, sleep, and mechanosensitivity significantly correlated with
spontaneous primary afferent activity (peripheral hyperexcitability). This study is an im-
portant step toward understanding the complex changes that occur after SCI. It is the first
to link sleep and respiration changes after SCI to peripheral hyperexcitability in mice and
supports previous studies linking pain to ongoing spontaneous pain fiber activity [48][136]
[137] [60] [118]. Moreover, we developed and applied novel approaches in noninvasive
behavioral analysis to uncover previously unknown and understudied components of SCI
pathogenesis.
2.5.1 Neural basis of neuropathic pain after SCI
Spontaneous primary afferent activity has been identified as a driver of chronic pain in
clinical [34][35] and preclinical [50][49][51] [52][54][48][59] studies. In SCI models of
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neuropathic pain, spontaneous activity in DRG neurons has been implicated in the develop-
ment of behavioral indications of sensory hyperexcitability [48][59][60]. But these studies
examined dissociated and cultured DRG neurons, a process which has been demonstrated
to induce spontaneous activity [119]. Here we recorded from intact DRGs from multiple
segments and confirmed that firing frequency and incidence of spontaneously active DRGs
are higher after SCI. Though our recording technique did not permit resolution for classi-
fying the spikes by primary afferent class, evidence suggests that spontaneous activity in
A and C fibers are associated with neuropathic pain [50][49][51] [52][54][48][59][55][35]
and have been observed in this particular SCI model [60].
Until recently, neural recordings of pain had been performed in isolation from the cog-
nitive behavioral assay putatively measuring pain in rodent models. A landmark study
[138] undertook in vivo recordings from populations of amygdalar neurons in naturally be-
having mice to ascertain and differentiate reflexive from affective motivational components
of pain. Their methods characterized a variety of evoked pain stimuli which allowed them
to map pain-encoding neurons in the amygdala. Importantly, they were also able to identify
that neuropathic pain activated the amygdalar pain matrix via non-pain encoding afferents.
Importantly, the entire affective/motivational component of pain but not spinal reflex ele-
ments were entirely dependent on activation of this matrix. This work provides a crucial
link between behavioral assays of pain and cognitive processing of pain, providing a more
stable platform to interpret traditional behavior tests of pain.
In SCI animals, we showed a correlation between the change in PWT and the DRG in-
cidence, where a greater reduction in PWT was observed in animals with a higher incidence
of spontaneously active DRGs. DRG firing frequency and incidence were not correlated,
suggesting that they may capture disparate aspects of ongoing pain or an alternate none pain
encoding sensory signaling pathway (e.g. metabolic status, baroreceptors, hypoxia). The
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incidence of spontaneously active DRGs may determine the size/number of dermatomal
regions impacted by neuropathic pain—where a larger incidence is associated with a larger
region impacted. Firing frequency could instead encode the intensity of pain experienced
by a single region. This could explain the link between PWT and DRG incidence. The
rodent hindpaw is innervated by axons with cell bodies in L3-L6 DRGs [139]. Broader
hyperexcitability of these lumbar primary afferents could contribute to greater hindpaw
sensitivity.
2.5.2 Behavioral methods to assess pain
Assessing pain in rodents is extremely challenging. While visual observation of ani-
mal grooming and social habits [140][118] can determine whether an animal may expe-
rience severe pain, these methods are unable to provide more than a qualitative assump-
tion of pain and these behaviors can be influenced by myriad other symptoms. Sev-
eral functional assessment assays (rotorod, grip strength, balance beam, Basso, Beattie,
Bresnahan (BBB) open field test, vermicelli test, swim test) are able to partially quan-
tify movement and task-related effects of pain [141][142][143][144]. Others (elevated
plus maze, open field, light-dark box, grimace scale) are able to estimate putative emo-
tional components of pain, though this is tenuous in mice which have highly adapted
prey responses [145][146][147][148]. However, the standard approach to quantify pain-
like behavior is through evoked tests (von Frey, Hargreaves, Mechanical Conflict System,
Randall-Siletto, tail flick, cold/hot plate, acetone evaporation) that measure an escape re-
sponse either through movement or vocalization [141][142][146][147][148]. Evoked be-
havioral tests of pain have been used for a variety of injuries and diseases with components
of pain, but they have not performed well when assessing spontaneous pain.
Evoked paradigms of testing identify sensory hypersensitivity, but it is unclear if or how
this hypersensitivity relates to increased spinal reflexes rather than the affective/motivational
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component of nociceptive processing that requires actions on brain circuitry including the
experience of chronic, spontaneous pain (Corder, Ahanonu et al. 2019)[138]. As men-
tioned above, Corder, et al, have been able to map pain-encoding neurons in the amygdala
and connect their activity with several standard evoked behavioral assays used for pain.
Importantly, that study confirmed that von Frey filaments applied to the plantar regions of
the hind paw to test mechanical hypersensitivity do activate pain-encoding neurons in the
amygdala. However, this does not preclude animal responses to evoked mechanical stimuli
are also affected by changes in reflex response and sensitization [149][150].
Multiple tests have been developed (conditioned place preference, burrowing tests,
weight bearing, gait analysis, thermal preference, automated home cages) to attempt to
quantify spontaneous pain [150][151][152][148][147][146][141][153]. A forerunner, the
conditioned place preference (CPP) assay offers method for measuring the affective/ mo-
tivational component of neuropathic pain. Findings suggest CCP successfully identifies
animals with neuropathic pain [120][121][122], but this method relies on the efficacy of
analgesics, animal mood, and training while having limited electrophysiological evidence
supporting the presence of ongoing pain activity [154]. Another test, also included in the
Corder, et al, neuropathic testing paradigm, determined that animals experiencing neuro-
pathic pain develop adaptive thermal cold avoidance behavior when given free movement
over a temperature gradient ranging from noxious cold (15°C) to preferred temperature
(30°C). Though able to identify animals with neuropathic pain, both CPP and thermal
gradient tests are unable to capture a spontaneous pain event at the time of occurrence
or quantify the severity of spontaneous pain experiences. The limitations of these assays
demonstrate a remaining need for behavioral metrics for measuring chronic, spontaneous
pain.
Based on other studies conducted by our group, respiration features may provide a
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method to identify specific spontaneous pain events. In unpublished data, our group mea-
sured respiration rate (RR) and variability (RRV) in awake, restrained mice before and
after an injection of formalin, causing a short-term noxious inflammatory pain response,
into the hind paw. These data showed increased RR corresponding with formalin. Like-
wise, other mice (observed in the same EF instrumented home-cages described in this SCI
study) received a hind paw injection of complete freund’s adjuvant (CFA), causing a long
term noxious inflammatory pain response, and developed increased RRV during sleep sim-
ilar to what we observed after SCI. Moreover, the hind paw mechanical sensitivity of CFA
mice correlated with RRV (p <0.001, R2 = 73) suggesting that pain may contribute to
RRV during sleep. Because we are able to measure respiratory features continuously, they
may be useful in pinpointing spontaneous pain as it occurs.
2.5.3 Sleep changes after SCI
When asked, individuals with SCI are likely to report increased difficulty falling asleep,
reduced sleep quality, a need for sleep medication and increased daytime sleepiness [155].
Even though the incidence of sleep dysfunction is greatly increased after SCI sleep dysfunc-
tion after SCI remains barely explored, and how this may impact various other comorbid
events in SCI remain completely unexplored. That SCI itself already challenges physio-
logical operation of sensory, motor and autonomic systems that impinge on cognition and
psychological well-being surely warrants understanding the interrelation between sleep,
emergent disorders and their normalization by controlling sleep.
Though SCI patients experience reduced sleep quality [123][124][125][126], there is
limited research on the cause-effect relations between sleep compromise and co-morbid
conditions after SCI, including chronic pain. While it is well established that sleep dis-
ruption and chronic pain are bi-directionally negatively reinforcing [124][156][125], their
association in SCI has not been detailed clinically or in preclinical animal models. Though
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there are several studies describing respiratory-related sleep dysfunction caused by cervi-
cal SCI [124][157][158], only one preclinical study (in rat) has reported non-respiratory-
related sleep dysfunction after SCI [159]. The scarcity of preclinical work quantifying
sleep changes after SCI is partially due to the invasiveness and difficulty in measuring ro-
dent sleep; current methods to rely on invasive EEG recordings that itself introduces extra
surgery, immune response, stress, and altered home cage environments that may complicate
behavioral changes and pain after SCI.
The technological advance of the EF sensors has allowed our group to be the first to non-
invasively quantify sleep changes in rodents after SCI. We observed that, after SCI, there
is an increase in brief arousals contributing to reduced duration of individual sleep events
and increased numbers of sleep events as the animals attempt to compensate. Though these
measures are interrelated, they each highlight a different aspect of sleep fragmentation:
sleep event duration helps infer whether an animal has had the opportunity to cycle through
the different stages of non-REM prior to entering REM or waking up. If the sleep event is
too short, it is likely the animal has not been able to achieve normal transitions for restora-
tive sleep. The number of sleep events adds a longitudinal component by helping capture
whether an animal’s normal division of sleeping and waking is altered. The number of brief
arousals confirms how frequently sleep disruptions are part of the animal’s normal sleep-
ing habits or whether sleep was prematurely interrupted and the animal attempts to enter
sleep again quickly [160][161]. SCI animals experienced a combination of these measures
strongly indicating disrupted, fragmented sleep.
Though sleep became more fragmented, the distribution of REM and non-REM was
not significantly disrupted and the animal slept the same total time of the 12-hour dark
cycle even, 6 weeks after SCI. However, though animals did not decrease their total time
asleep, their sleep events started out grouped together at two time points during the dark
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cycle (peaking at midnight and again at 3 am), but became evenly scattered across the 12
hours 6 weeks after SCI. Given the heightened mechanical sensitivity and increased SA
DRGs after SCI, it would be intuitive to hypothesize that REM sleep would be reduced
after SCI due to premature arousal caused by the concert of movements that define REM
sleep. However, REM sleep is highly variable and occupies such a small proportion of
total sleep time (5-15%), any change may have been overshadowed by inherent variability.
Additionally, REM sleep occurs immediately prior to natural arousal, thus it is difficult to
tell whether REM sleep resolved prior to arousal or caused premature arousal.
2.5.4 Linking pain and sleep dysfunction after SCI.
Many individuals with SCI have persistent ongoing spontaneous neuropathic pain [162]
[163] [164] [165] [166] [167]. This pain is among the most disruptive and disabling forms
of chronic pain with enormous impairment in daily activities and with a strong affective
dimension (e.g. anxiety and depression) [168][169]. Evidence of ongoing spontaneous
pain has been demonstrated in rodents [48][136][170][60][170], and should lead to similar
alterations in affective state and daily activity. Yet this is difficult to measure [171]. Despite
its importance, very few studies have been undertaken that assess spontaneous pain.
It is intuitively obvious that disrupted sleep and pain can coexist in a mutually rein-
forcing cycle of suffering. As observed clinically, pain can result in poor sleep quality
[172][173]. In individuals with SCI, poor subjective sleep quality was associated with
higher ratings of pain intensity, anxiety, and depression [156]. Chronic pain can increase
arousals during sleep to reduce overall sleep quality [174]. Conversely, sleep impairments
impact pain, including the development and maintenance of chronic pain, perhaps more
reliably so than the reverse[173]. In preclinical animal models, sleep disruption can cause
acute and long-lasting hypersensitivity to painful stimuli [175] and it leads to mechanical
sensitivity in both healthy and peripheral nerve-injured rats [176].
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Currently there is very limited preclinical animal studies devoted to assessing sleep
changes after SCI. Emphasis is on respiratory-related sleep disorders resulting from cervi-
cal SCI [127][128][129]. Only one study looked at and observed sleep dysfunction inde-
pendent of respiration [159]. In our studies we observed a shift to dysfunctional sleep after
SCI. This presented as increases in sleep event count and brief arousal count, along with a
decrease in median sleep event duration; all of which indicated more segmented sleep. In
the SCI population, the change in sleep event count correlated with the incidence of spon-
taneously active DRGs-where a larger increase in sleep event count (indicative of increased
sleep disruption) occurred in animals with a higher DRG incidence. If DRG incidence cor-
responds to the number of dermatomes impacted by pain, it is reasonable to assume that
these animals may experience pain over a larger surface area that coincides with greater
difficulty sleeping.
There was also a positive correlation between DRG firing frequency and RRV, suggest-
ing that a higher magnitude of spontaneous primary afferent activity at a single segment
may be related to more erratic breathing, after injury. One possibility is that these affer-
ents are not associated with conventional pain pathway but project to brainstem central
autonomic circuitry that do not lead to the experience of pain [177].
2.6 Conclusions
Peripheral hyperexcitability has been previously observed in SCI models of neuropathic
pain. Here we found correlations between spontaneous lumbar DRG activity (incidence
and firing frequency) and metrics of sleep and respiratory dysfunction–complications fre-
quently observed in SCI patients. The findings suggest that in addition to examining pri-
mary afferent activity, non-contact recording of sleep and respiratory features may serve as
a useful tool for identifying the emergence of persistent spontaneous neuropathic pain in
animal models of SCI.
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2.7 Research Contributions
Training for animal surgeries and use of the Infinite Horizons (IH) impactor was provided
by Kamarcha Martin and the Garraway Lab, headed by Dr. Sandra Garraway. Animal surg-
eries were performed by Shaquia Idlett-Ali and Mallika Halder. Tissue isolation, electro-
physiology experimentation, and analysis was performed by Shaquia Idlett-Ali. Behavioral
testing and analysis was conducted by Dr. Heidi Kloefkorn. Shaquia Idlett-Ali authored
this chapter with collaboration from Dr. Heidi Kloefkorn and Dr. Shawn Hochman.
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CHAPTER 3
CHARACTERIZATION OF AXONAL RECRUITMENT WITH SCS
3.1 Abstract
Spinal cord stimulation (SCS) is used clinically to limit chronic pain, but fundamental ques-
tions remain on the identity of axonal populations recruited. We developed an ex vivo adult
mouse spinal cord preparation to assess recruitment following delivery of clinically analo-
gous stimuli determined by downscaling a finite element model of clinical SCS. Analogous
electric field distributions were generated with 300 µm x 300 µm electrodes positioned 200
µm above the dorsal column (DC) with stimulation between 50 and 200 µA. We compared
axonal recruitment using electrodes of comparable size and stimulus amplitudes when con-
tacting the caudal thoracic DC and at 200 or 600 µm above. Antidromic responses recorded
distally from the DC, the adjacent Lissauer tract (LT), and in dorsal roots (DRs) were found
to be amplitude and site dependent. Responses in the DC included a unique component not
seen in DRs, having the lowest SCS recruitment amplitude and fastest conduction velocity.
At 200 µm above, mean cathodic SCS recruitment threshold for axons in DRs and LT were
2.6 and 4.4 times higher, respectively, than DC threshold. SCS recruited primary afferents
in all (up to 8) caudal segments sampled. Whereas A and C fibers could be recruited at
nearby segments, only A fiber recruitment and synaptically mediated dorsal root reflexes
were observed in more distant (lumbar) segments. In sum, clinically analogous SCS led to
multisegmental recruitment of several somatosensory-encoding axonal populations. Most
striking is the possibility that the lowest threshold recruitment of a nonprimary afferent pop-




Peripheral somatosensory afferents enter the spinal cord via dorsal roots and many issue
axon collaterals into the most prominent white matter tract known as the dorsal column
(DC). The DC contains axons of large diameter Aαβ myelinated primary afferents that
encode complex sensory information on touch and proprioception [16]. Though these
myelinated primary afferents are the predominant DC constituent, unmyelinated axons and
ascending projections from spinobulbar postsynaptic dorsal column (PSDC) tract neurons
also reside in the DC [12][13][15][14][16]. PDSC tract neurons are known to receive multi-
convergent synaptic inputs from various primary afferents [16]. Immediately lateral to the
DC is the Lissauer tract (LT) which is largely comprised of primary afferent axon collater-
als (predominantly C fibers) and implicated in the regulation of spinal receptive field size
and gating of pain transmission [11][178].
Epidural spinal cord stimulation (SCS) can depress refractory pain signaling via elec-
trodes positioned at the posterior (dorsal) epidural space above the DC. Approximately
50,000 stimulators are implanted yearly for patients diagnosed with various pain syndromes
with failed back surgery syndrome having among the highest success rates [62][179]. SCS
is thought to recruit DC Aβ fibers and inhibit pain via the Gate Control Theory of Pain.
This theory postulates that antidromic Aβ fiber excitation inhibits nociceptive transmis-
sion through the action of inhibitory interneurons within the dorsal horn [80][180]. It has
been assumed that Aβ fiber recruitment from a single dermatome is the core mechanism
of SCS-induced pain control even though SCS may also recruit other neuronal popula-
tions (e.g. postsynaptic dorsal column tract cells) and despite its inability to explain many
clinical observations [99][3][95][2].
Most experimental inquiries into mechanisms underpinning the actions of SCS utilize
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in vivo studies with anesthetized rodents in well-characterized models of neuropathic pain
[181][100][114]. Several have used amplitudes scaled relative to motor threshold to assess
modulation of nociceptive transmission in pain models [106][96][97][111][107]. However,
basic questions on the identity of axons recruited have not been convincingly addressed.
Here, we used dimensional electrode scaling and model-based identification of SCS pa-
rameters to inform experimental assessments of axon fiber recruitment properties in DC,
dorsal roots (DRs), and LT using ‘clinically analogous’ SCS. LT’s proximity to DC, and
subsequently the SCS electrode, potentially presents an alternate site of recruitment and
modulation.
We examined variability in axonal recruitment to several preclinical SCS parameters
including stimulation site, stimulation distance, amplitude, polarity and pulse duration.
Results from these studies answer fundamental questions regarding the recruitment of dif-
ferent fiber populations and segmental circuits.
This work has been presented previously in abstract form [182][183], and has been
published as a journal article [184] .
3.3 Materials and Methods
3.3.1 Preclinical electrode scaling
To conduct preclinical experiments in the mouse with clinically-analogous SCS, the elec-
trode dimensions were scaled with reference to clinical contact sizes and the mediolateral
and dorsoventral dimensions of the adult mouse spinal cord (Figure 3.1A, 3.1B). For both
rat and mouse, T10 spinal cross-section profiles were generated by tracing the gray mat-
ter and white matter boundaries over one side of the T10 spinal segment, according to
the cross-section from the anatomical atlas [185], reflecting the traced profile of the hemi-
sphere over the midline of the segment, and concatenating the original and reflected tracings
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to form a symmetric cross-section (Figure 3.1C). The magnitude of the differences in the
lengths of the major and minor axes between an unscaled rat T10 spinal segment and scaled
mouse T10 spinal segment, was plotted as a function of the mediolateral and dorsoventral
scaling factors applied to the mouse spinal segment (Figure 3.1D). Major and minor axis
lengths for both the rat and mouse spinal cord were determined respectively from the maxi-
mum mediolateral and dorsoventral extents of the white matter tracings. The scaling factor
generating the minimum error in cross sectional area between the mouse and rat spinal seg-
ment (rat:mouse, 1:1.8) was then related to the human to rat scaling factor of (human:rat,
1:2.5) previously determined; with the overall scaling between human to mouse spinal cord
being (human:mouse, 1:4.5) An atlas of the rat and mouse spinal cord [185] provides high
resolution images at all spinal levels from rat and mouse as well as a specific scaling factor
between human and rat thoracic cord—from which we derived the human-to-rat translation
factor and then determined that the rat and mouse thoracic cord are qualitatively anatom-
ically similar. However, no direct scaling data from human to mouse was included in the
reference—hence the intermediate step. Based on these scaling factors, verbatim scaled
contacts will have lengths of 0.67 mm and widths of 0.30 mm. As dorsal columns are orga-
nized by dermatome in the medial-lateral direction [18][19], and as approaches to improve
the spatial selectivity of SCS have focused on constraining the medial-lateral dimension
of the activation region [69][186], subsequent model simulations were conducted using
square contacts with side lengths corresponding to the smaller medial-lateral dimension of
the scaled down clinical electrodes (0.3mm x 0.3mm). Constraining electrode dimensions
seemed advantageous for experimental studies of recruitment as this allowed for greater
specificity in target of SCS, aiding in analysis and understanding of experimental outcomes.
3.3.2 FEM model: mouse spinal cord
A three-dimensional finite element model (FEM) of both the in vivo mouse spinal cord
and the ex vivo mouse spinal cord recording setup was created in COMSOL Multiphysics
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Figure 3.1: Preclinical electrode scaling.
A) Examples of a 1x8 clinical cylindrical percutaneous lead and a 4x8 clinical paddle lead pro-
vided by Boston Scientific. The contact dimensions are 3mm x 1.35mm and 3.18mm x 1.4mm,
respectively. The appropriate size of SCS electrodes for subsequent computational modeling and
preclinical experimentation was determined by scaling the dimensions of these contacts with respect
to the cross-sectional area of the mouse spinal cord. B) Comparison of relative sizes of human, rat
and mouse T10 spinal cord. C) Example mouse cross-section generated from an anatomical atlas of
the spinal cord. The cyan and orange lines depict the gray and white matter boundaries, respectively.
D) Rat and mouse error comparisons for major and minor axes: magnitude of the differences in the
lengths of the major and minor axes between an unscaled rat T10 spinal cord and scaled mouse
T10 spinal cord, plotted as a function of the mediolateral (major) and dorsoventral (minor) scaling
factors applied to the mouse spinal cord. Colors denote the magnitudes of the total difference in
lengths of the major and minor axes measured in mm. This analysis supports rat:mouse scaling
factor of 1.8 (white box). When related to the previously determined human:rat scaling factor, the
human:mouse scaling factor is 4.5.
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(Version 5.1, COMSOL Inc., Burlington, MA) to compare the electric fields (and thereby
currents) generated by the scaled down electrodes in the experimental preparation with
those expected to be generated by the same electrode in an in vivo mouse and by a com-
mercial epidural lead in a human. For the in vivo FEM, the dimensions of the CSF space,
dura, epidural fat, and vertebral bony layers were generated by downscaling the x and y
dimensions of the corresponding anatomical features from a previously published FEM of
the human thoracic spinal cord [94] by factors of 4 and 4.5, respectively, derived from the
previously described scaling procedure. Dirichlet boundary conditions (V = 0) were used
at the lateral and dorsoventral boundaries of the model, and Neumann boundary conditions
(n •J = 0) were used at the rostrocaudal boundaries of the model. For the ex vivo FEM, the
model was scaled according to the actual experimental setup and consisted of an insulated
rectangular chamber measuring 76 mm in length, 45 mm in width, and 8 mm in depth filled
with artificial CSF and a 1 mm diameter ground wire placed 10 mm from the center of the
stimulation lead(Appendix A.1). In the ex vivo model, the faces of the ground wire were
set to Dirichlet boundary conditions (V = 0), and the other outer boundaries of the model
were set to Neumann boundary conditions (n •J = 0).
An extruded mouse spinal cord 35 mm in length and a model of the experimental stim-
ulation lead were preserved across both the in vivo and ex vivo models. The dimensions
of the gray and white matter of the mouse spinal cord were obtained by directly tracing
the left half of a slice image of the Mouse T10 spinal cord [185] and reflecting the tracing
over the midline using MATLAB (Version R2015a, MathWorks, Natick, MA) before being
imported into COMSOL. Furthermore, the gray matter was displaced 20 µm ventrally from
the original tracing to allow the spacing between the dorsal gray matter and white matter
boundary to fulfill the minimum mesh element size requirement of the finest mesh setting
in COMSOL (approx. 15.2 µm). Stimulating leads were modeled as conductive thin cu-
bic domains with a side length of 0.3 mm surrounded by a rectangular insulating substrate
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Table 3.1: Tissue conductivities and isotropy used in finite element models of the mouse
spinal cord. Values were based upon and updated from Lee et al. 2011[94].
Tissue Isotropy and Conductivities(σ if isotropic, σx, σy, σz if anisotropic; units S/m)
Gray Matter Isotropic, σ = 0.23
White Matter Anisotropic, σx = 0.083, σy = 0.083, σz = 0.60
CSF Isotropic σ = 1.70
Dura Isotropic σ = 0.6
Epidural Fat Isotropic σ = 0.04
Conductor Isotropic σ = 5 •106
Insulator Isotropic σ = 1 •10−7
Bone Isotropic σ = 0.02
with outer dimensions of 2.4 mm X 0.6 mm X 0.5 mm and suspended from an insulating
cylindrical electrode mount 0.4 mm in diameter and centered on the rectangular substrate.
The ventral surfaces of each contact on each lead were each set to a uniform current density
with Neumann boundary conditions corresponding to the total stimulation amplitude (50,
200 µA) divided by the surface area of each lead [187]. Stimulation currents from each of
the two contacts were set to the same amplitude at opposite polarities to depict the electric
field generated by bipolar stimulation in the spinal cord proximal to the leads. Domain
conductivities representing tissues and materials of interest are shown in Table 3.1, and
domain permittivities were set equal to the permittivity of free space, consistent with the
quasi-static assumption [188]. Results for each model were then obtained by solving for
Laplace’s Equation (∇•σ∇V = 0) over an adaptively scaled tetrahedral mesh.
Constant-current stimulators provide compliance voltages that automatically adjust to
the tissue impedance. Boundary conditions of the model were set with this in mind. As
significant clinical variability exists in patient perception thresholds, the theoretical out-
comes of the model are representative of electric field strengths expected. The amplitude
57
of current delivered to the mouse model was scaled using the intended experimental ge-
ometry for the voltages and electric fields to conform to the clinical ranges without severe
discrepancies. One clear limitation of the mouse model is that it represents a scaling from
this normalized, exemplary range.
3.3.3 Spinal cord isolation
All procedures were approved by the Emory University Institutional Animal Care and Use
Committee: C57/Bl6 mice (both sexes, n=35, P60 and older) were anesthetized with ke-
tamine (100mg/kg) and xylazine (10mg/kg) mix by intraperitoneal injection, following
light anesthetization in an isoflurane chamber. To induce tissue hypothermia, the dorsal
skin overlying the vertebral column was removed and mice were placed in an ice bath until
there was a noticeable slowing of the respiration rate (2-3 minutes) prior to decapitation
and isolation of spinal cord in a dish containing ice cold, oxygenated (95% O2 / 5% CO2)
low-Ca2+ artificial cerebral spinal fluid (aCSF) containing (in mM), [NaCl 128, KCl 1.9,
MgSO4 13.3, CaCl2 1.1, KH2PO4 1.2, glucose 10, NaHCO3 26]. The isolated cord was
equilibrated to room temperature for 1 hour, then pinned dorsal side up in a Sylgaard-
lined recording chamber while superfused with an oxygenated aCSF containing (in mM),
[NaCl 128, KCl 1.9, MgSO4 1.3, CaCl2 2.4, KH2PO4 1.2, glucose 10, NaHCO3 26], at
˜40ml/minute. All experiments were undertaken at room temperature.
3.3.4 Histological test of spinal cord viability
In 4 experiments, 8 hours following spinal cord isolation and experimentation, the spinal
cord was fixed in 2% paraformaldehyde for two hours, rinsed with phosphate buffer so-
lution (PBS), sectioned with a vibrating blade microtome (Leica VT1000S) in 300 mi-
cron thick slices, and stained 30- 60 min in 1:250 Neurotrace (N-21482/Molecular Probes)
mixed in PBS with 0.3% triton, then washed twice in PBS without triton. Captured images
of stained slices allowed assessment of neuronal anatomical integrity (Nikon Eclipse E800
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microscope with DXM1200 camera).
3.3.5 Electrophysiology
The DC is largely comprised of myelinated Aαβ primary afferents fibers that transmit pro-
prioceptive and mechanosensitive information but also includes ascending projections from
PSDC tract neurons and unmyelinated axons, while the neighboring LT mostly consists of
C fibers with short-range projections and Aδ nociceptors with long-range projections [11]
(Figure 3.2A).
Experimental characterization of axonal recruitment was conducted with clinically-
analogous SCS using a bipolar electrode constructed of two glass electrodes (300 µm tip
diameters, 1.5-2 mm separation) filled with aCSF, and positioned (rostrocaudally) medial
over the DC, typically in caudal thoracic segments (T9-T11; Figure 3.2B). Circular glass
electrodes were used for experimental studies due to the repeatability of the construction
process relative to manual cutting of 300 x 300 µm electrodes. A constant-current stimu-
lator [189] was used to deliver a single monophasic pulse of bipolar SCS while contacting
(0 µm) or above the spinal cord DC (200 or 600 µm). Stimulation amplitudes were incre-
mentally increased from 1 to 500 µA with 50, 200, 500 µs pulse durations, for assessments
of recruitment threshold. The advantage of a constant-current stimulation protocol, based
on modeling studies, is that resistivity values normally seen for dura and arachnoid do not
significantly affect spinal cord current densities [86]. Thus, our experimental arrangement
excludes the presence of dura but still is expected to realistically appraise neural system
recruitment at defined electrode configurations and distances from the spinal cord at the
stimulus intensities applied.
Glass recording suction electrodes were positioned in the lumbar spinal cord on the DC
(200 µm tip diameter), DR (200-250 µm tip diameter), and LT (1-2µm tip diameter, 3-5
59
MΩ). Targeted recording of LT was accomplished by positioning a glass microelectrode
lateral to the dorsal column, in between dorsal root entry zones. Appropriate positioning
was confirmed by stimulating the ipsilateral spinal cord 1-3 spinal segments rostral to the
recording site and observing that the conduction velocity of evoked response was slower
than that recorded in DR and DC of the same segment. Recruitment threshold was de-
fined as the lowest stimulus amplitude producing a greater than 50% response rate in any
recording location. Since threshold was typically lowest for DC axonal recruitment (see
Results), relative thresholds for recruitment were standardized as the multiple of DC re-
cruitment threshold (TDC) necessary to elicit responses in LT and DR. All recorded data
were digitized at 50 kHz (Digidata 1322A 16 Bit DAQ, Molecular Devices, U.S.A.) with
pClamp acquisition software (v. 10.7 Molecular Devices). Recorded signals were ampli-
fied (5000x) and low-pass filtered at 3 kHz using in-house amplifiers. Unless otherwise
stated, reported results are for cathodic stimulation 200 µm above the cord with 200 µs
pulse duration. Recruitment order trends for cathodic and anodic stimulation were similar,
despite difference in polarity. Cathodic stimulation, in some cases, recruited populations
at a similar or lower threshold and SCS experimental studies utilizing monophasic stimu-
lation frequently report observations based on cathodic stimulation [100][111][110][107].
This is likely due to knowledge that cathodic stimulation recruits neural tissue at lower
amplitudes than anodic stimulation [190][191][192]. For these reasons, we chose to focus
our reporting on cathodic stimulation. In all data presented, the number of animals utilized
for analysis is represented by the noted n-value. For each animal, a representative value
was determined by averaging the response from multiple sweeps/trials within that animal
(a minimum of 5).
3.3.6 Electrode configurations for estimating conduction velocity
Central CV was calculated based on the distance between the site of SCS and the recording
electrode. Specifically, central CV of recruited axons was measured between the cathodic
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Figure 3.2: Ex vivo adult mouse preparation: experimental setup and viability.
A) Examples of a 1x8 Schematic of gross anatomy of spinal cord from dorsal surface and simplified
organization of axon fiber populations subject to recruitment by SCS (inset). Axonal recruitment
with SCS was assessed in dorsal roots (DR), dorsal column (DC), and Lissauer tract (LT). While
the DC predominately carries non-nociceptive sensory information, the neighboring LT contains
projection from nociception transmitting primary afferents. B) Schematic of general experimental
paradigm. Two electrodes (about 1.5mm apart) are placed on or above the medial DC in a region be-
tween T9 and L3. This is used to simulate a bipolar SCS system. Responses to SCS are recorded via
glass suction electrodes on the DC and DRs and a microelectrode on LT. inset: orientation of bipole
(cathode-black, anode-red) and direction of current flow for cathodic and anodic stimulation used
for experimental studies. R and C denote rostral and caudal, respectively C) Post-experimentation
Nissl staining revealed persistent cellular viability 8 hours after cord isolation (top) but dramatic
deterioration when superfused for 2 hours in the absence of oxygenation (bottom).
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electrode used for stimulation and distal recording electrodes placed either near the midline
of the dorsal column or more laterally at the dorsal root entry zone. To estimate peripheral
CV, we positioned two suction electrodes on individual DRs at least 3 mm apart (L3, L4, or
L5) to calculate differences in time of arrival of the antidromic afferent volley [193]. CVs
of different volley components were calculated post-hoc to identify the afferent classifica-
tions (i.e. Aαβ, Aδ, C) using published findings of primary afferent CV in dorsal roots
at room temperature [6][193]. The fastest conducting components observed likely include
antidromic responses of proprioceptive (group I&II; here denoted as Aα) and cutaneous
afferents (Aβ). For uniformity with previous publications we label the fastest conducting
myelinated components as Aαβ fibers responses.
Statistical differences in recruitment threshold, with respect to SCS stimulation distance
(0, 200, and 600µm), were analyzed using Ordinary one-way ANOVA with Tukey correc-
tion for multiple comparisons. Differences between the relative recruitment thresholds of
DC, DR, and LT were analyzed using the Friedman test with Dunn’s correction for multiple
comparisons. Analysis of conduction velocity differences were performed using a paired
t-test. Unless otherwise stated, the results are presented as the mean ±SD with statistical
significance being ascribed at p <0.05.
3.4 Results
3.4.1 Anatomical evidence of viability
Nissl positive neuronal staining was observed in tissue fixed 8 hours after experimentation.
As a control, a spinal cord isolation was conducted using the same procedures except the
cord was superfused without oxygen for two hours, which lead to a near complete absence
of Nissl stain (Figure 3.2C). Demonstrated viability and increased access to the spinal neu-
raxis without anesthetics supported the use of this ex vivo model for electrophysiological
investigations on SCS.
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3.4.2 Preclinical finite element analysis model
Preclinical stimulation was simulated using a bipolar electrode consisting of two square
contacts, dimensions which are noted above, with an edge-to-edge spacing of 1.2 mm and
positioned epidurally over the dorsal surface at the midline of the spinal cord, for both the ex
vivo and in vivo models described above. The clinical standard for SCS electrode placement
involving SCS at conventional frequencies associated with paresthesia-based SCS involves
implantation of the electrode at the T7-T8 vertebral segments, with the intent of targeting
the dorsal column fibers coursing through the T9-T10 spinal cord level. Using a mouse
model of the T9-T10 spinal cord is consistent with this therapeutic approach and with prior
literature [194]. The electric field magnitudes generated during ex vivo preclinical SCS (50
to 200 µA), with a cerebrospinal (CSF) fluid layer of 0, 200, or 600 µm, were compared
to those generated in the clinical model with a typical range of SCS amplitudes (3 and 10
mA). Results from analysis were used to guide experimental investigations in the ex vivo
adult mouse spinal cord. Qualitatively, preclinical SCS positioned 200µm (50-200 µA)
above the spinal cord in the ex vivo model generated electric field distributions comparable
to those generated by clinical SCS (Figure 3.3). Preclinical SCS 0 µm above the spinal
cord with the same amplitudes (50-200 µA) suggests broader recruitment of populations in
the DC and dorsal horn, than would be observed in the clinical SCS; indicating that lower
stimulation amplitudes than those modeled would be advised for analogous recruitment.
While, stimulation 600 µm above suggests that higher amplitudes of stimulation would be
necessary to capture the range of electric field distributions observed in the clinical case.
Comparisons between ex vivo and in vivo preclinical cases suggests that while 200 µm is
suitable for the ex vivo preclinical SCS, 600 µm in vivo most closely mimics the relative
CSF thickness in human and the bone, fat, and dura contributes to the generation of com-
parable electric field distributions with stimulation this distance above the cord (Appendix
B.1).
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Figure 3.3: Finite element modeling of electric field magnitudes identifies stimulation am-
plitudes for clinically- analogous SCS in the adult mouse.
A) Rostrocaudal orientation of bipole for clinical (left) and preclinical (right) SCS. The anode (red)
is rostral over the spinal cord (T9) and the cathode (blue) is caudal over the spinal cord (T10). Scales
capped at ±0.4 V, scale bars correspond to 5mm and 0.5mm B) Clinical: Electric field magnitudes in
the human spinal cord during stimulation generated using a finite element model of clinical bipolar
SCS with a clinical 1x8 percutaneous lead with amplitudes in the typical range. C) Preclinical
ex vivo: Electric field magnitudes in the spinal cord during SCS generated using a finite element
model of the ex vivo mouse spinal cord (absence of dura, epidural fat, and bone) in a rectangular
bath of cerebrospinal fluid, equivalent to experimental conditions. The properties, mesh settings,
and boundary conditions of the finite element model are consistent with that of the clinical model
except that all dimensions have been scaled down by a factor of 4.5. Stimulation was simulated
using a bipolar electrode consisting of two square contacts of side length 0.3 mm with an edge-
to-edge spacing of 1.2 mm and positioned epidurally 0, 200, or 600 µm over the dorsal surface
of the midline of the spinal cord. The fields generated at 200 µm above the spinal cord are most
comparable to those generated in the clinical conditions.
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3.4.3 SCS recruits afferents that invade multiple dorsal roots and
conduct at velocities consistent with all primary afferents
Multisegmental recruitment was directly assessed with bipolar SCS (50 and 200 µA, 200
µs) positioned 0 µm (n=5) or 200 µm (n=3) above the DC. Afferent recruitment was seen
in all caudal DRs sampled, the most caudal being 8 spinal segments away (Figure 3.4).
In the example shown, T9/T10 SCS recruitment was abolished following DC lesion above
T11 demonstrating that stimulation recruited axons at the stimulation site with subsequent
antidromic propagation to DRs. CVs were divided into three categories approximating
reported peripheral CVs of Aαβ (>4.2 m/s), Aδ (0.56-4.2 m/s) and C fibers (<0.56 m/s) at
room temperature [6].
To accurately identify afferent classes based on peripheral CV, we used the two-point
recording method in DRs (Figure 3.4B; Table 3.2). We observed a rostrocaudal distance-
dependence of electrode position on afferent recruitment. By reducing stimulus amplitude
(50µA), we also observed that low amplitude SCS only recruited A fibers in DRs from
nearby spinal segments (0-3 segments away; n=8) and that higher amplitude SCS (200µA)
was required to recruit A fibers in more distant dorsal roots (n=7; Figure 3.4B; Table 3.2
). Higher amplitude and longer pulse duration SCS also recruits slower conducting Aδ
and C fibers in DRs of nearby segments (Figure 3.4B; Table 3.2). Though recruitment
of C fibers was not observed in DRs distal to SCS, we cannot exclude the possibility that
multisegmentally-projecting unmyelinated C fibers [195] were undetectable due to disper-
sion of the volley.
3.4.4 SCS evokes synaptically-mediated recruitment of primary afferents
Dorsal root potentials (DRPs) and dorsal root reflexes (DRRs)—resulting from primary af-
ferent depolarization (PAD)—were observed with SCS. These longer latency, synaptically-
mediated events had variable onset latency and amplitude (observed in 13 of 23 animals).
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Figure 3.4: SCS recruits primary afferents that invade multiple segmental dorsal roots and
conduct at velocities consistent with all classes of sensory fibers.
A) SCS directly activates afferent axons that project to multiple caudal spinal segments. A single
pulse of SCS (200µA, 200µs) was applied 200 µm above T9/T10 and antidromic responses in select
caudal DRs (T11-L5) were recorded before (black) and after (red) DC lesioning above T11 with
iridectomy scissors. Lesion of the DC blocked all stimulus-evoked responses in DRs. Each trace is
the average response of 10 sweeps. B) Distant dependent recruitment of afferent fiber populations
can be identified by differences in peripheral CV. Here, bipolar SCS was applied 200 µm above
T11/T12 or L2/L3 at amplitudes of 50 and 200 µA (500µs). T11/T12 SCS led to the recruitment of
A fibers in the L5 DR, but only at the higher stimulus amplitude (at arrow). In comparison, SCS at a
closer segment (L2/L3) recruited A fibers at the lower intensity with higher magnitude stimulation
leading to recruitment of slower conducting C fibers (at arrows). Each trace is the average of 6
sweeps. The peripheral conduction velocities estimated using this configuration are summarized in
Table 3.2. The gray box identifies the location of stimulation artifact.
Table 3.2: Distant dependent recruitment of different classes of primary afferents with SCS.
The peripheral conduction velocity of dorsal root afferents was determined using the two-
point method on lumbar roots, with SCS positioned 200µm above the dorsal column. This
table displays the conduction velocity (mean±SD) of the fastest components in each class
of afferents when SCS was applied closer to (A) or further from (B) the DR recording
site (for schematic, see Figure. 3.4C). Afferent classification was determined as described
previously [6]. In cases where recruitment was observed in less than half of experiments, a
null value is listed (-) to best depict the general recruitment result.
A. SCS 7-9 Segments Rostral (n=7)
Amplitude (µA) 50 200




Aαβ - - - 9.6±3.7 12.9±4.8
Aδ - - - 3.3±0.3 3.4±0.9
C - - - - -
B. SCS 0-3 Segments Rostral (n=8)
Amplitude (µA) 50 200




Aαβ 12.7±8.0 11.7±4.5 12.2±8.3 15.3±8.0 15.7±7.7
Aδ - - - 2.3±1.2 2.4±0.9
C - - - - 0.4±0.03
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Recordings at the dorsal root entry zone (DREZ) permitted observation of both events, with
suprathreshold DRRs’ arrival coinciding with the presence of the DRP (Figure 3.5A,Bi).
Recordings away from the DREZ led to observations of only DRRs. The jitter and sen-
sitivity of this activity to bicuculline (10 µM, n=4) confirmed it as synaptically-mediated
(Figure 3.5B).
Two distinct populations of DRRs were commonly observed in lumbar DRs, the earliest
event being 9.0 ±1.6 ms after the onset of the direct antidromic response, with the second
DRR event occurring 9.2 ±1.2 ms later. Thresholds for direct antidromic axonal recruitment
and synaptically-mediated (indirect) DRRs were comparable with mean threshold for DRR
recruitment being numerically only 3.8 ±2.2 µA higher than the antidromic event (n=5; p
>0.05, paired t-test; Figure 3.6). This suggests that the indirect recruitment is activated by
excitation of low threshold primary afferents. The population(s) of axons receiving primary
afferent depolarization was not identified, but the presence of two different populations of
DRRs suggests that one population may be initiating PAD, while two separate populations
could be receiving PAD (Figure 3.5C); though it is also possible that the second DRR event
reflects recurrent activity initiated by the first DRR event or doublet firing within the same
recruited axons.
3.4.5 Characterization of dorsal column recruitment with SCS
Dorsal column recruitment was also characterized in the adult mouse spinal cord as de-
picted in Figure 3.7A (left). Recruitment of axons in DR, DC and LT was compared
when SCS was contacting (0 µm), 200 µm, or 600 µm above the spinal cord (n=12).
Direct recruitment of axons in LT was identified based on a lack of variability in onset la-
tency and amplitude (Figure 3.7A, bottom right). Recruitment order and relative thresholds
of recruitment was then determined by increasing the magnitude of constant-current SCS
(200µs pulse width; Figure 3.7A). Interestingly, when SCS electrodes were contacting or
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Figure 3.5: SCS recruited GABAergic presynaptic inhibitory pathways observed as
bicuculline- sensitive DRPs and DRRs.
A) SCS-generated DRP with suprathreshold DRRs recorded at the L5 dorsal root entry zone. By
convention negativity is presented upwards to convey the DRP as primary afferent depolarization.
The grey box indicates the location of the stimulus artifact and truncated direct antidromic axonal
volley preceding the slow DRP. The average response is presented overlaid (black) with 10 indi-
vidual events underneath to demonstrate variability in timing of individual DRRs (grey). B) SCS
evokes DRP and DRRs that are blocked following application of the GABAA receptor antagonist
bicuculline (10 µM). Bi) Presented are averages of 10 sweeps from the T13 dorsal root entry zone.
Both DRP and DRRs are blocked after the addition of bicuculline (blue). Bii) Bicuculline-sensitive
DRRs are seen in the absence of an underlying DRP. Shown are 6 events overpaid from a L2 DR
recording obtained further from the root entry zone. In both panels, grey box indicates the location
of the stimulation artifact and direct primary afferent recruitment. C) Schematic depicting possi-
ble circuitry responsible for GABAergic actions on afferent axons leading to a form of presynap-
tic inhibition called primary afferent depolarization (PAD), here experimentally observed as DRPs
and DRRs. SCS antidromically recruits Aαβ afferent axons responsible for recruiting the spinal
circuit leading to PAD. Aαβ afferents synaptically recruit last-order GABAergic interneurons via
interposed interneurons or directly (depicted with dotted line). GABAergic axo-axonic synapses
on primary afferents activate bicuculline-sensitive GABAA receptors that mediates the Cl- efflux
to produce PAD. As these experiments cannot identity of afferent axons generating PAD possible
actions on all afferent classes as shown
68
Figure 3.6: SCS evokes direct and indirect primary afferent recruitment at comparable
thresholds.
SCS was applied contacting (0 µm) (A) or 200 µm above (B) T9/T10 while recording a lumbar DR.
Stimulus amplitude was incrementally increased (1-200 µA, 200 µs) and the recruitment threshold
for direct primary afferent recruitment and synaptically-mediated primary afferent activity (indirect)
was identified post-hoc. Mean threshold for indirect recruitment was not significantly higher than
that observed for direct recruitment when SCS was applied contacting (0 µm, n=4; 15.2 ±10.1 vs.
13.0 ±6.9 µA, respectively) or 200 µm above (n=5, 49.8 ±48.3 vs. 48.0 ±52.3 µA, respectively)
(Aii, Bii, paired t-test). Black arrows indicate direct recruitment, dashed grey boxes denote indirect
recruitment, while dark grey boxes depict the stimulation artifact. Black lines are the average of 6
traces.
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above the DC, axonal recruitment was first seen in the DC regardless of stimulation polarity
(n=12). The mean threshold current for recruitment with SCS contacting the DC was lower
for cathodic (6.3±4.3 µA) than anodic (9.1±3.7 µA) stimuli (p<0.05, n=12). When stim-
ulation was positioned 200 or 600 µm above the spinal cord, recruitment thresholds were
similar at 30.5±26.6 (cathodic) vs. 26.3±13.3(anodic) (p=0.213, n=12), or 231.9±127.5
(cathodic) vs. 278.5±106.0 (anodic) (p=0.125, n=10), respectively. Compared to thresh-
olds observed with SCS contacting the spinal cord DC, threshold values were ˜3-5 times
higher at 200 µm above (p <0.05) and 31-37 times higher at 600 µm above the DC (p
<0.001; Figure 3.7B). Thresholds for SCS positioned 600 µm above were 8-11 times that
seen with placement 200 µm above (p <0.001).
3.4.6 Relative thresholds for dorsal roots and Lissauer’s tract recruitment
We also compared the relative recruitment of antidromic events in DR and LT relative
to the threshold seen in dorsal column (TDC) when SCS was contacting or positioned
above the DC (n=12; Figure 3.7A,C). When contacting the DC, events in DR and LT were
recruited at 3.8±2.4 (p<0.05) and 5.0±4.5 (p<0.001) times TDC , respectively. At 200 µm
above, events in DR and LT were recruited at 2.6±1.0 (p<0.05) and 4.4±3.1 (p<0.0001)
times TDC , respectively. In comparison, there were no differences in relative recruitment
threshold between DR and LT when touching (p >0.9) or when 200 µm above (p= 0.26).
At 600 µm above, only DC recruitment was seen in most experiments (n=7/10), even at
maximal current amplitudes (>200 µA). However, when DR and LT recruitment was seen,
both thresholds were similar to TDC , being 1.5±0.4 (n=5) and 1.5±0.1 (n=2) times TDC .
No axonal recruitment was elicited in 3 of 10 experiments with placement 600 µm above.
3.4.7 Comparison of the lowest-threshold axons in dorsal column and dorsal roots
The one-point method was used to compare the central CVs of the first recruited com-
ponents in DC and DR (at entry zone) at the same segmental level (Figure 3.8A). On
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Figure 3.7: SCS recruitment thresholds are lower for dorsal column axons.
A) Example configuration for investigations of recruitment threshold and order. To identify the
recruitment threshold of dorsal axon tracts, bipolar SCS (T9/T10, 1-600µA, 200µs) was applied
contacting or above the spinal cord, with simultaneous recordings of DR, LT, and DC at the same
segmental level. In the example above DC (purple) is recruited first at threshold (TDC), with DR
(green) recruitment observed at 1.7x TDC and LT (blue) recruitment observed at 2.3x TDC . The
light gray box identifies the location of the stimulation artifact, while the arrows point to dashed
boxes denoting the presence of indirect recruitment/reflexes. The colored trace is an average of
6 sweeps. B) ThresholdDC (TDC) was determined with stimulation 0, 200, or 600µm above the
T9/T10 (n=12). TDC significantly increased at 200 µm above and 600 µm above (* p <0.05,
*** p <0.001, matched one-way ANOVA, Tukey’s multiple comparison). C) DC recruitment was
observed at the lowest threshold and significantly lower than threshold for DR and LT for SCS at 0
(n=12) or 200µm (n=12) above the spinal cord. With SCS 600 µm above, recruitment beyond DC
was observed in only n=2 out of 10 cases. The plot depicts the mean and SD for the test conditions.
(* p<0.05, *** p<0.001, **** p<0.0001, Friedman test with Dunn’s multiple comparisons).
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average, the CV of the first detectable recruited DC component is 43-69% faster that the
first observed DR component. This observation was independent of stimulation duration
and distance (p <0.01). Results of this analysis are summarized in Table 3.3.
Figure 3.8: The lowest threshold recruited fibers in DC and DR differ in conduction veloc-
ity and relative recruitment properties.
A) The conduction velocity (CV) of the first recruited component in DC is greater than that of the
DR (n=12), as confirmed by the paired t-test (Aii ***, p = 0.0001, SCS position 0 µm above).
Table 3 contains the results from different stimulation conditions. B) The strength-duration rela-
tionship for the first recruited populations in DC and DR differed (n=5) with rheobase (Bii) and
chronaxie (Biii) being lower in DC than in DR (Wilcoxon matched-pairs signed rank test,* p<0.05
SCS positioned 0 µm above). (Bi) Strength-durations curves for DC and DR are plotted by fitting a
one-phase decay exponential model (RMSE 4.6 and 16.4, respectively) to the mean and SD of the
threshold values for 50, 200, and 500 µs pulses.
The strength-duration relationship of the lowest-threshold detectable axons in the DC
and DR was assessed with SCS contacting the DC (Figure 3.8B). Rheobase and chronaxie
were determined by fitting a one-phase decay exponential to the cathodic threshold values
in DC and DR with SCS pulse durations of 50, 200, and 500 µs (n=5). Both rheobase and
chronaxie values were significantly lower for DC axons. Mean values for rheobase were
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Table 3.3: Central conduction velocity for SCS-evoked responses in dorsal column and
dorsal root.
Conduction velocities were measured with simultaneous recordings in the dorsal column
and the dorsal root entry zone, at sites caudal (L1 or L2) to the SCS electrode (T9/T10).
Shown is the mean±SD conduction velocity of the lowest threshold fibers in the dorsal
column and dorsal root at room temperature. Statistical analysis was performed using the







Mean Conduction Velocity (m-s−1) N
DC DR
0
50 4.9±1.7 2.9±1.3∗∗∗∗ 12
200 4.6±1.3 3.0±1.1∗∗∗ 12
200 200 4.3±0.9 3.0±0.8∗∗∗∗ 12
600 200 5.0±1.2 3.1±0.9∗∗ 5
3.5±1.5 µA for DC and 8.0±3.8 µA for DR (p<0.05). Chronaxie values were 133.3±32.8
µs and 180.2 ±38.6 µs for DC and DR, respectively (p<0.05).
To assess possible differences in recruitment with medial and lateral electrode place-
ment along much of the rostrocaudal axis, we recorded from 9 DRs sampled between T3-S2
(n=4) while stimulating with our SCS electrode at T9-T10 and simultaneously recording
from DC at L3 (Figure 3.9A). Across DR recordings, recruitment thresholds (relative to
DC threshold) were lower with lateral compared to medial placement (except at T3), with
the largest shift occurring in thoracic roots closest to the site of stimulation (Figure 3.9B).
With all samples grouped across animals (medial/lateral, 36 samples each), there was a
significant difference between DR relative recruitment threshold for medial and lateral
placement, (p<0.05, Friedman test with Dunn’s multiple comparisons). Nonetheless, DC
threshold was always lower than DR recruitment threshold regardless of SCS mediolateral
placement (p<0.0001, Figure 3.9C).
To further demonstrate that the DC contains an axonal population distinct from those in
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Figure 3.9: The low DC threshold observed is independent of mediolateral position of SCS.
A) Schematic of experimental paradigm: 9 DRs across T3-S2 spinal segments were recorded with
a simultaneous recording of the L3 DC. Recruitment thresholds of both populations were assessed
with medial and lateral SCS placement (T9/T10). B) Thresholds of DRs rostral and caudal to the site
SCS were greater, relative to the DC threshold (dotted line at y=1). (n=4). C) Grouped samples
from n=4 (9 roots sampled each, 36 total samples for both medial and lateral placement) shows
that while lateral placement leads to a reduction in the relative DR threshold (*, p<0.05), both
medial and lateral placement have higher thresholds than DC (dotted line at y=1), for recruitment,
(# p<0.0001, Friedman test with Dunn’s multiple comparisons). Bar charts display mean and SD.
the DR, we undertook dual-site SCS collision experiments to selectively block conduction
in the lowest threshold axons not projecting to DRs (n=4). DC-contacting monopolar SCS
electrodes were placed two thoracic segments apart (T10 and T12) for dual-site stimulation
(Figure 3.10). Caudally conducting axonal volleys were recorded and compared in the DC
and DR at the same lumbar segment. Stimuli were adjusted so that T10 SCS only recruited
an antidromic volley in the DC while higher intensity T12 SCS recruited volleys in both
DC and DR. When T10 SCS preceded T12 SCS by a 2 ms interval, preferential conduction
block in the DC volley was seen in all experiments (to 22±8% vs. of control amplitude),
leaving the DR volley largely unaffected (volleys 93±7% of control amplitude; p<0.05).
Figure 3.10B shows examples recorded at L3 and L5 spinal segments. Thus, conduction
block of the lowest threshold DC axons does not impair antidromic recruitment of dorsal
root afferents.
Overall, these experiments show that T9/10 thoracic SCS recruited a distinct population
of axons in lumbar DC with lower threshold and faster CV than antidromically-identified
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primary afferent responses recorded in homologous segmental lumbar DR axons. As SCS-
recruited DC axons also had lower threshold than antidromically-activated primary affer-
ents that originated from DRs spanning the 19 spinal segments sampled (T3-S2), it is highly
unlikely these axons are of primary afferent in origin.
Figure 3.10: Collision testing further supports lowest threshold axons in DC as distinct
from DR axons.
Conduction block of the lower threshold DC axons at the same segment as recruited DR does not
block antidromic recruitment of DR afferents. A) Electrode configuration for comparison of re-
cruited axonal volleys recorded in the DC and DR of the same lumbar segment following monopo-
lar SCS at T10 and T12 thoracic segments. B) Shown are comparison axonal volleys recruited in
the DC (upper row) or DR (lower row) of the same lumbar segment when T10 and T12 SCS stim-
uli were delivered individually or sequentially (T10 then T12) with a 2 ms interstimulus interval.
Stimulus onsets are marked by red arrows and stimulus artefacts are identified as grey boxes. Bi)
T10 SCS stimulation at lower intensity preferentially evoked an antidromic volley only in the L3DC
(left), while T12 SCS at higher intensity evoked recorded volleys in the L3DR and L3DC (middle).
The amplitude of the T12 SCS evoked volleys in DC and DR are shown bounded by a red dashed
box for comparison with amplitudes observed after collision testing when T10 SCS preceded T12
SCS (right). There was preferential conduction block of axons in their refractory state in the DC
volley (top row) while the DR volley (bottom row) was largely unaffected (compare red boxed re-
gions). Bii) Preferential conduction block of the DC volley was also seen at the L5 spinal segment.
3.5 Discussion
We developed an isolated ex vivo adult mouse spinal cord preparation as an accessible
platform to characterize the axonal populations recruited following delivery of SCS using
electrodes scaled to generate clinically-comparable electric fields. To our knowledge, these
are the first studies employing quantitative methods to scale multiple SCS parameters for
experimental studies on recruitment in smaller mammalian models.
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With SCS electrodes placed above the caudal thoracic cord (T9/T10), primary exper-
imental observations include the following: 3.5.1) Compared to afferent recruitment near
the SCS electrode (0-3 segments away), higher stimulus amplitudes were required for an-
tidromic recruitment of Aαβ afferents at more caudal dorsal roots (7-9 away). These higher
amplitudes also lead to antidromic recruitment of slower conducting fibers near the stim-
ulation site (Table 3.2). 3.5.2) In lumbar cord dorsal roots, direct antidromic activation of
Aαβ afferents also corresponded with recruitment of bicuculline-sensitive (GABAergic)
presynaptically inhibitory actions on terminals of unidentified primary afferents (recorded
as DRPs and DRRs). 3.5.3) The lowest-threshold fastest-conducting axons recruited at
lumbar segments were preferentially recruited in the dorsal column (DC) and at thresholds
significantly lower than seen for afferents in dorsal roots (DRs) or the Lissauer tract (LT).
These axons retained the lowest recruitment threshold with SCS placed more laterally and
compared to primary afferent recruitment that originated from distant DRs (spanning T3-
S2 spinal segments). Based on known anatomy and process of exclusion, they are possibly
PSDC ascending tract cells. The implications of these observations are elaborated below.
3.5.1 Factors affecting multisegmental recruitment of primary afferents: evidence beyond
convention
The capacity for SCS electrodes to antidromically recruit afferents across many spinal seg-
ments demonstrates that SCS is capable broad axonal activation beyond the segment/ der-
matome of interest. While clinically, stimulation parameters are determined by identifying
the regime that leads to a region with the greatest paresthesia perception (e.g. paresthesia
dermatome focus) overlapping with the region of pain, the complete paresthesia percep-
tion can cover a broader dermatomal area [94][64]. This suggest that the population of
axons responsible for the paresthesia can be recruited simultaneously at multiple spinal
segments, while one segment may have the greatest recruitment. We also show that the
higher stimulus amplitudes and longer pulse durations required for antidromic recruitment
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of faster-conducting myelinated fibers at more distant segments can also recruit putative
pain-encoding unmyelinated C fibers closer to the stimulation site (Figure 3.4). This obser-
vation predicts that SCS aimed at selective recruitment of myelinated fibers would benefit
from use of lower magnitude/short pulse durations placed at spinal segments closer to the
targeted site for modulation.
The strength-duration relationship predicts that increases in pulse duration and am-
plitude enhance axonal recruitment. Clinically, increased SCS duration has resulted in
observations of the elicited paresthesia spreading to multiple dermatomes [196]. Longer
pulse durations resulted in marked increased recruitment of smaller-diameter medial dorsal
column axons which is consistent with sacral shifts in paresthesia coverage [94]. Higher
stimulation amplitudes have been associated with increased cross-sectional area of DC re-
cruitment [87]. We observed differences in rheobase and chronaxie for DC compared to
DR populations. Such measures are not normally estimated with extracellular stimula-
tion because obtained values strongly depend on distance of axons from stimulation site.
Nonetheless, SCS leads to threshold and CV differences between DC and DR populations,
and differences quantified on the basis of a strength duration curve may be of instructive
importance for subsequent consideration of stimulation strategies. For example, shorter-
duration higher-intensity pulses could increase separation of DC from DR while longer
duration pulses at lower stimulus intensity may more uniformly recruit both populations.
Computational studies also suggest that DR/primary afferent recruitment may be re-
lated to discomfort thresholds in patients with SCS [87][84], and this may be due to co-
recruitment of Aδ fibers. Our observation that the increased stimulus strength required
to recruit Aαβ fibers from distant caudal segments also recruits smaller diameter (Aδ, C)
fibers from nearby segments (Figure 3.4C) may underlie unwanted side effects at a differ-
ent dermatome reported clinically [197].
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Recruitment requiring increased stimulus amplitudes from more distant segments is
consistent with earlier observations [20][21]. As smaller diameter afferent axons have
higher thresholds for activation by extracellular stimuli [198][199] these observations have
been interpreted as a distance-dependent reduction in diameter of ascending axons [200][201].
Recruitment differences may also reflect somatotopic differences in axon diameter of functionally-
distinct Aαβ fiber populations [19].
Our experimental results with clinically-analogous SCS suggest that a non-primary af-
ferent DC axon population is recruited first (detailed in section 3.5.3, below). SCS-evoked
responses in DR (Aαβ) and LT (presumably Aδ) are then subsequently recruited at similar
several-fold higher intensity (Figure 3.7). While recruitment beyond DC was not always
observed with SCS 600 µm above the cord, when broader recruitment was observed, DR
and LT were recruited at comparable relative thresholds. Aβ and Aδ recruitment thresholds
were also reported to be similar following DC stimulation in rat [112]. While Aδ fibers are
not thought to project in the DC [8][17] (however for monkey and cat see [21][202] ), that
LT is immediately adjacent and contains Aδ fibers that project many segments [11] may
support their similar recruitment threshold by SCS.
Observed negligible recruitment thresholds differences in DR (Aαβ) and LT (presum-
ably Aδ) is a significant observation since the primary conceptual basis of SCS modulation
of pain is via selective recruitment of Aβ fibers that act via inhibitory mechanisms associ-
ated with the Gate Control Theory of Pain [180]. We are unaware of experimental literature
that demonstrates SCS selectively recruits Aβ afferent fibers.
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3.5.2 Aαβ primary afferent recruitment coincides with recruitment of spinal circuits mediating
presynaptic inhibition of primary afferents
We related clinically-analogous SCS to segmental distribution of recruited afferents fiber
classes. While we observed broad rostrocaudal antidromic recruitment of primary afferents
originating from many spinal segments, we focused on assessment of axonal recruitment
that would correspond to an equivalent expected distribution in humans with failed back
surgery syndrome [64]. In mouse this roughly corresponds to L1-3 segments [203]. We
show that T10 SCS at the lower modeled intensity of 50 µA recruited the lowest thresh-
old primary afferents as well as spinal circuits that have been associated with presynaptic
depression of primary afferent input (described below). These results are consistent with
demonstration of dermatomal overlap and activation of circuitry that could modulate pain
signaling. While one might view this as encouraging, whether such afferent recruitment
is causally linked to pathways that generate paresthesia and/or modulate pain is unknown
(also see Section 3.5.4).
Primary afferent depolarization (PAD) is thought to arise predominantly from GABAer-
gic axo-axonic synapses acting on GABAA receptors that cause a Cl− efflux constituting
an ionotropic form of afferent presynaptic inhibition [204][205]. Figure 3.5C depicts sim-
plified representation of circuitry generating axo-axonic presynaptic inhibition of primary
afferents. Here PAD was experimentally recorded as a slow depolarizing dorsal root poten-
tial (DRP) and/or dorsal root reflex (DRR). DRRs represent suprathreshold spiking arising
from an underlying slower depolarizing DRP [204] and their expression here is likely due
to bath temperature [206][207].
An important observation was that threshold for recruitment of the lowest threshold
(Aαβ) primary afferents was comparable to threshold for recruitment of interneuronal cir-
cuits responsible for generating presynaptic inhibition by PAD and DRRs (Figure 3.5).
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While SCS recruited Aαβ afferents to recruit the circuitry mediating PAD, the identity of
the primary afferent axons receiving presynaptically-inhibited via PAD cannot be deter-
mined from these experiments. They likely include negative feedback onto functionally
homologous Aαβ primary afferents [204] but could also include actions on C fibers, and
hence suppress central actions of nociceptors [208].
3.5.3 Are axons of PSDC neurons the lowest threshold axons recruited with SCS?
We observed that the lowest threshold axons recruited at lumbar segments with SCS had
differentiable recruitment properties (CV, rheobase, chronaxie) compared to DR afferent
axons. That these axons had lower threshold and were distinct from primary afferent
axons recorded along the rostrocaudal axis explored (T3-S2) argues against them being
collateral branches of primary afferents originating from more rostral or caudal segments
[17][19][209]. Dual-site SCS collision experiments demonstrated ability to selective block
these DC axons independent DR afferent axon recruitment, further supporting their axonal
identity as distinct from primary afferents.
Postsynaptic dorsal column tract cells (PSDCs) are ascending tract neurons that project
via the DC to brainstem gracile nuclei [16] and may be the non-primary afferent axonal
population recruited by SCS. Aαβ primary afferent axons enter the DC, project both ros-
trally and caudally, and regularly issue axon collaterals out to gray matter as they project
[17][19]. In contrast, PSDCs are not thought to issues collaterals after entering the DC (see
Figure 3.11) [13]. In the absence of branching, PSDCs may retain the higher values of CV
reported here and previously [210][211][212][213].
3.5.4 Are orthodromic actions of PSDC neurons responsible for SCS paresthesias?
The possibility that PSDCs are the non-primary afferent DC axon population recruited at
intensities lower than Aαβ primary afferents (Figure 3.7; see below) may indicate their im-
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portance in SCS induced modulation of pain that could be independent of peripheral side
effects. Assuming activation of Aαβ afferents is responsible for evoking motor reflexes
that define motor threshold in clinical SCS approaches [95], and given that that SCS is ef-
fective at amplitude values below motor threshold, recruited axons may include PSDCs. As
PDSCs receive multimodal afferent input [210][214][212][213][215] and project to dorsal
column gracile nuclei [13], their orthodromic activation by SCS could be directly respon-
sible for initiating paresthesias. Lumbar PSDCs represent ˜30% of the cells that project to
the gracile nucleus, while only ˜25% of lumbar enlargement long system primary afferents
reach the gracile nucleus [17][13]. Importantly, as PSDC neurons are largely absent in the
thoracic cord [13], PSDC axons recruited at T10 would originate from caudal segments
consistent with locations of observed paresthesia reported clinically [216][24]. In contrast,
the observed broad rostrocaudal recruitment of sensory axons with T10 SCS (Figure 3.9)
is consistent with anatomical projections of Aαβ fibers in the DC known to originate from
many segments above and below the SCS site [17][19]. It would be harder to causally link
broad afferent recruitment to the selective generation of paresthesias caudal to the SCS site.
An interesting possibility is that paresthesias and depression of pain perception are
both due to PSDC actions. As PSDC tract neurons only issue local axon collaterals near
their cell bodies in the dorsal horn [211], antidromic recruitment of PSDCs located in
lumbar segments could synaptically interact with other spinal neurons that then modu-
late lumbar spinal sensory transmission [215]. It is also possible that PSDCs activate
supraspinal antinociceptive mechanisms, including that of the descending serotonergic sys-
tem [99][105][101]. Overall, preferential PSDC recruitment may represent a critical but
currently unexplored neural circuitry underlying conventional SCS-induced paresthesia and
analgesia.
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3.5.5 Factors associated with experiments conducted in the isolated adult mouse spinal
cord
We developed an ex vivo adult mouse spinal cord preparation that permitted detailed elec-
trophysiological investigations without anesthetic-interference. To enhance viability, stud-
ies were conducted at room temperature. The concomitant slowing of conduction velocity
aided separation of Aαβ, Aδ and C fiber volley components when recording along rela-
tively short distances, but did not provide the actual values of conduction velocities that
would be seen in vivo. Guidelines for classifying primary afferents in DRs at room tem-
perature were obtained from a study that characterized CV in peripheral nerve and DRs at
22 and 37°C [6]. Nissl staining suggested that dorsal horn neurons are preserved and elec-
trophysiological recordings demonstrated neuronal participation in synaptically-mediated
DRRs. However, it is likely that circuit excitability may be depressed via unknown mecha-
nisms including cord transection induced spinal shock [217]. Recordings of afferent evoked
population synaptic responses as field potentials in the dorsal horn suggested limited re-
cruitment of polysynaptic pathways unless excitability was increased pharmacologically
(preliminary observations). As distinct descending brainstem systems are known to be
involved in SCS pain modulation [99], its removal represents a further limitation of the
isolated spinal cord model system. However, modern genetic approaches enable studies on
neuromodulatory actions from brainstem in the isolated spinal cord via optogenetic activa-
tion of their descending axons [218].
Traditional preclinical SCS studies are primarily undertaken in the rat in vivo. They
vary in their electrode design (ball, paddle, monopolar, bipolar, etc.) and often assign SCS
intensity as a percentage of motor threshold (e.g. 70-90%) [106][97][98][111][107]. Our
experimental paradigm leveraged computational modeling to inform detailed recruitment
studies to realistically appraise neural system recruitment with clinically-analogous stimuli
at defined electrode configurations and distances from the spinal cord - features not present
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in previous preclinical studies of SCS. To achieve this, we strategically developed a model
system that allowed us to explore this with optimal access to the dorsal column, dorsal
roots and SCS distance above the cord. Obtained results inform subsequent SCS studies
in mouse using scaled electrodes and effective stimulus frequencies to determine whether
the delivered currents have modulatory actions on known afferents/pathways including in
mouse in vivo pain models.
Importantly, though our experimental arrangement excludes the presence of dura, at the
constant current stimulus intensities applied, resistivity values normally seen for dura do
not significantly affect spinal cord current densities [86]. Changes from the modeled elec-
trodes (square) to those utilized for experiments (circular) account for an overall surface
area difference of 0.02 mm2. While it is possible that this difference could affect recruit-
ment when SCS is contacting the cord surface, there is little evidence to suggest that a
difference of this scale would significantly impact relative recruitment thresholds and re-
cruitment order of axonal populations when stimulating through CSF. The main point of
the electrode scaling technique was to quantitively estimate relevant dimensions for studies
with the mouse spinal cord. Previously, rodent studies frequently employed contacts with
dimensions that are larger than what would be recommended for a mouse [109][111][95],
including those comparable to electrodes used clinically [97][98][100][107].
3.6 Conclusions
We paired clinically-analogous SCS with an experimentally-accessible adult mouse spinal
cord preparation to provide detailed studies on the variability in axonal recruitment to sev-
eral preclinical SCS parameters including stimulation site, stimulation distance, amplitude,
polarity and pulse duration. Results demonstrate a hierarchical sensitivity of recruitment
of various axonal populations and introduce the possibility that the primary actions of SCS
may be independent of primary afferent recruitment. Figure 3.11 summarizes the proposed
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anatomical relation between relative axonal recruitment.
Figure 3.11: Factors associated with differences in SCS recruitment of Aαβ afferents and
non-primary afferent fiber populations.
A) Shown are anatomical considerations in relation to axonal recruitment results. SCS recruited
Aαβ axons originating from both rostral and caudal spinal segments. An additional non-primary
afferent population was recruited at lower threshold in the lumbar DC. Based on known anatomy,
these are likely PSDC tract cells. PSDC axonal recruitment would be expected to have direct ortho-
dromic actions in brainstem gracile nuclei that associate with sensory integrative actions within the
lumbar cord. PSDC antidromic axonal recruitment may have segmental synaptic actions on lumbar
circuits via local intraspinal axon collaterals. Aαβ afferent axons would have widespread rostro-
caudal spinal synaptic actions including via GABAergic presynaptic inhibition of primary afferent
signaling, and also project directly to the brainstem gracile nuclei. B) Cross section of dorsal spinal
cord at level of SCS (T10) depicts how differences in axon depth and diameter may explain relative
recruitment threshold and conduction velocity (CV) in these axonal population. Lumbar DC axons
(putative PSDCs) have the lowest threshold and fastest CV. Lumbar Aαβ have slower CV that may
be explained by a smaller axon diameter while their higher threshold may be due to greater depth
and/or smaller diameter. Thoracic Aαβ had lower threshold values relative to DC axons. This is
partly explained by lateral location but may also be due to greater location depth. Thoracic Aαβ
CV was not estimated.
3.7 Research Contributions
This chapter was adapted from an article published in the Journal of Neurophysiology
[184]. Scaling procedures and finite element modeling were performed by Dr. Tianhe
Zhang and Dr. Natalie Brill (Boston Scientific). Tissue isolation, electrophysiology exper-
imentation, and analysis was performed by Shaquia Idlett-Ali and Mallika Halder. Shaquia
Idlett-Ali authored this chapter with collaboration from Dr. Shawn Hochman.
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CHAPTER 4
SCS MODULATION IN AN EX VIVO MODEL OF SPONTANEOUS
HYPEREXCITABILITY
4.1 Abstract
Spinal cord stimulation is used clinically for relief of chronic neuropathic pain. The gate
control theory presents a theoretical framework of the therapy’s mechanism of action, but
the true mechanisms remain unclear. Typically, preclinical studies investigate mechanisms
leading to modulation of stimulus-evoked pain, despite the critical ability for spinal cord
stimulation to modulate chronic, stimulus-independent pain. Here, we utilize a spinal cord-
dorsal root ganglia preparation to generate a model of spontaneous hyperexcitability in
sensory circuits using 4-aminopyridine (4-AP). We first demonstrate that 4-AP induced
activity of axons in lumbar dorsal roots and in Lissauer’s tract with subjacent neurons in
the superficial dorsal horn (LT/DH). Then we test the gate control theory by investigating
modulation of spontaneous nociceptive activity with T9-T11 spinal cord stimulation (SCS)
at dorsal column and dorsal root recruitment thresholds. In the 4-AP model of sensory hy-
perexcitability, spontaneous activity manifested three distinguishable events; (i) episodic
rhythmic dorsal root potentials with superimposed burst firing, (ii) episodic field poten-
tials with superimposed spikes in LT/DH, and (iii) additional spontaneous spiking events
in dorsal roots and LT/DH. We also observed that dorsal column threshold SCS at 50 Hz
modulated spontaneous spiking activity in LT/DH during SCS but could not modulate the
episodic field potentials or produce prolonged modulation following cessation of stimula-
tion. These results demonstrate the utility of a 4-AP model of spontaneous hyperexcitability
and the limited and perhaps antagonistic contribution of gate control, via Aβ recruitment,
to SCS modulation of spontaneous nociceptive activity.
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4.2 Introduction
Spinal cord stimulation (SCS) is a clinical therapeutic for ongoing, stimulus-independent
neuropathic pain. Conventional SCS is undertaken at frequencies between 20-150Hz. SCS
is presumed to act by selective recruitment of larger diameter non-pain encoding Aβ axon
collaterals in the dorsal column that suppress pain afferent signaling by the gate control
theory of pain. Though this mechanism of pain control is an attractive model, there re-
mains limited experimental evidence detailing the neurobiological underpinning of SCS-
induced pain modulation. To investigate mechanisms of action, preclinical investigations
frequently explore modulation of stimulus-evoked hypersensitivity in nerve injury mod-
els [95][96][97][98][99][100][101][102][103][104] [105] [106] [107] [108] [109] [110]
[219]. To our knowledge, no experimental studies investigate its role in modulation of
stimulus-independent persistent pain—a key clinical feature of SCS pain relief. Sponta-
neous activity generated centrally and peripherally has been identified as potential source
of neuropathic pain. Increasing evidence suggests the involvement of continuous primary
afferent activity in the development of chronic pain [50][49][51][52][54][55][35] [48] [59],
with dysregulation of voltage-gated K+ channels in dorsal root ganglion neurons emerging
as an initiator of the abnormal sensory activity [59]. Spontaneous activity also presents as
a potential selective target of SCS, as acute evoked pain can still be perceived with SCS
[81][82][220][83].
Here we report on the development of an ex vivo multisegmental spinal cord-dorsal
root ganglia (SC-DRG) preparation as a system for testing whether SCS modulates spon-
taneous hyperexcitability in spinal sensory circuits. We focus on pharmacologic induction
of spontaneous hyperexcitability using 4-aminopyridine (4-AP) to block voltage-gated K+
channels [221][222][223][224] as 4-AP has been shown to alter spinal circuitry in a manner
consistent with the emergence of rhythmic spontaneous neuropathic pain [223]. We first
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characterize the actions of 4-AP on central and peripheral targets, observing their distinct
manifestations of spontaneous hyperexcitability. We then examine the potential for SCS
to modulate spontaneous nociceptive activity, using threshold-based stimulation to test the
gate control theory and elucidate the mechanism leading to depression of pain.
4.3 Methods
4.3.1 Multisegmental spinal cord-dorsal root ganglia preparation
All procedures were approved by the Emory University Institutional Animal Care and Use
Committee: C57/Bl6 adult mice (both sexes, n=16, P60 and older) were anesthetized
with ketamine (100mg/kg) and xylazine (10mg/kg) mix by intraperitoneal injection, fol-
lowing light anesthetization in an isoflurane chamber. To induce tissue hypothermia, ice
was packed on top of the vertebral column, following removal of the overlying dorsal skin.
Animals were euthanized via decapitation and the vertebral column below the C5 verte-
bra (with surrounding ribs and muscle) was excised and pinned in a Sylgaard-lined dish
containing ice cold, oxygenated (95% O2 / 5% CO2) high-Mg2+/low-Ca2+ artificial cere-
bral spinal fluid (aCSF) containing (in mM), [NaCl 128, KCl 1.9, MgSO4 13.3, CaCl2
1.1, KH2PO4 1.2, glucose 10, NaHCO3 26]. In later sections I abbreviate the name of this
aCSF as “low Ca2+ aCSF”. Both a complete laminectomy and vertebrectomy were pre-
formed to expose the spinal cord (SC), dorsal roots (DR), and dorsal root ganglia (DRG)
from segments C8 through S1. The ex vivo preparation (Figure 4.1A) was equilibrated
to room temperature for 1 hour, then pinned dorsal side up in a Sylgaard-lined recording
chamber while superfused with an oxygenated aCSF containing (in mM), [NaCl 128, KCl
1.9, MgSO4 1.3, CaCl2 2.4, KH2PO4 1.2, glucose 10, NaHCO3 26], at ˜40ml/minute. All
experiments were undertaken at room temperature.
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4.3.2 Electrophysiology
Glass suction recording electrodes were positioned in the lumbar spinal cord on DRs (200-
250 µm tip diameter) for characterization studies and in Lissauer’s tract (LT) (1-2µm tip
diameter, 3-5 MΩ) for modulation studies. A glass recording suction electrode was also
positioned in the lumber spinal cord on the dorsal column (DC) (200 µm tip diameter) to
determine threshold for DC axonal recruitment (TDR; see section 4.3.5 ). Characterization
consisted of identifying the dose-response features of the 4-AP model and investigating
the role of synaptic transmission in the generated spontaneous activity. Modulation studies
investigated the potential for SCS to reduce spontaneous activity in LT and the superficial
dorsal horn (DH). We exclusively focused on LT/DH as their activity is consistent with
recruitment of nociceptive circuits [223] Targeted recording of LT was accomplished by
positioning a glass microelectrode lateral to the dorsal column (DC), in between dorsal
root entry zones. Appropriate positioning was confirmed by stimulating a DR one seg-
ment caudal to the recording site and observing preferential recruitment with 200 or 500 µs
pulse durations, indicative of high threshold afferents (Figure 4.1B, 4.1C). Both spiking
and extracellular field potentials (EFPs)–reflecting population synaptic responses–could be
observed with the microelectrode, confirming the ability to observe spontaneous nocicep-
tive activity in LT/DH. All recorded data were digitized at 50 kHz (Digidata 1322A 16 Bit
DAQ, Molecular Devices, U.S.A.) with pClamp acquisition software (v. 10.7 Molecular
Devices). Recorded signals were amplified (5000x) and low-pass filtered at 3 kHz using
in-house amplifiers.
4.3.3 Model of sensory hyperexcitability
A broad-spectrum voltage-gated K+ channel blocker, 4-AP, was utilized to generate a
model of sensory circuit hyperexcitability in the ex vivo SC-DRG preparation. 4-AP has
been demonstrated to increase the excitability of neurons in preclinical and clinical stud-
ies [222][225][223] and recruits spinal nociception-encoding circuitry consistent with the
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emergence of spontaneous neuropathic pain [223]. To characterize the dose-response re-
lationship of the model, 4-AP was bath applied at increasing concentrations (5-40µM)
during recording of a lumbar DR. To demonstrate that dorsal horn circuitry was involved
in generating the emergence of dorsal root potentials (DRPs), reduction in the responses
to 4-AP (30 µM) were compared in the presence of bicuculline (BIC, 10-20µM), to block
GABAA receptors presumed responsible for generating primary afferent depolarization (PAD)
underlying the DRPs, or after bath replacement with a low-Ca2+ aCSF to limit synaptic
transmission. Burst frequency and amplitude was quantified, when appropriate.
To determine whether 4-AP increased spontaneous activity in primary afferents directly,
DRGs and distal DRs were isolated in a minibath using a plastic barrier with petroleum jelly
sealant. If single-unit spiking was observed, tetrodotoxin (TTX) was increased serially to
concentrations of 20, 50, and 500 nM (10 minutes each) in order to deduce the classes of
primary afferents [221][6] activated by 4-AP as Aβ, Aδ, and C fibers, respectively [221]
[6].
For studies on modulation of nociceptive activity by SCS, 20µM 4-AP was bath ap-
plied during simultaneous recordings of lumbar of LT/DH and a DR. The following fea-
tures of the LT/DH activity was quantified before, during and after SCS: frequency of all
synaptic events (EFPs) (∆baseline>0.1mV), frequency of large synaptic events (∆baseline
>0.15mV), and frequency of single-unit spikes (∆baseline >0.35mV).
4.3.4 Fos labeling
To obtain histological evidence of 4-AP induced activation of nociceptive circuitry in the
dorsal horn, we stained spinal cord slices for c-fos protooncogene activation of the protein
Fos —an indirect metabolic marker for neuronal activity [226]. In accordance with a pre-
vious study [227], we electrically stimulated a lumbar DR at a high intensity (200 µA, 500
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µs) at 10 Hz for 10 mins, followed by a 2-hour incubation period. Electrical stimulation
served as a positive control for subsequent studies. For the 4-AP experiment, we applied 4-
AP for 10 mins, followed by a wash out and 2-hour incubation period. These experiments
were conducted at 27 °C, as Fos-immunoreactivity (Fos-ir) was previously demonstrated
to be temperature-dependent [227].
Following experimentation, the cord was then removed from the recording chamber
and fixed in 4% paraformaldehyde for 2 hours. After fixation the cord was placed in 20%
sucrose in phosphate buffered saline (PBS) until sectioning. The following processing
methods were adapted from Alexander et. al. 2015 [228]. Transverse sections 20 µm thick
were cut through the lumbar cord on a freezing microtome and mounted on slides. Sections
were washed in 0.01 M PBS with 0.1% Triton X-100 (PBS-T), blocked for 1 h in 5%
normal goat serum in PBS-T, and incubated at room temperature overnight in rabbit anti-
Fos antibody (1:250; Santa Cruz Biotechnology) in PBS-T with 2% goat serum. Sections
were washed in 3×PBS-T and incubated with donkey anti-rabbit conjugated to Cyanine
Cy3 (1:250; Jackson Immunoresearch) for 2 h at room temperature. Sections were then
washed in PBS three times and coverslipped.
Fos-ir in the spinal cord was quantified by visual counting of cells in the dorsal horn
showing nuclear staining. Positive staining cells were counted separately in dorsal horns
ipsilateral and contralateral to the stimulated root. Counts were pooled to calculate an
average and standard deviation of the number of dorsal horn cells expressing Fos protein.
4.3.5 Spinal cord stimulation
To explore modulation of spontaneous activity with electrical stimulation, mouse-scaled
electrode dimensions were utilized to generate clinically-analogous SCS with a constant-
current stimulator (previously described in Chapter 3) [184]. A single pulse of SCS (200
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µs) was applied contacting (0 µm) the thoracic DC (T9-T11) while stimulation amplitudes
were increased incrementally from 5 to 50 µA, to determine the recruitment thresholds
for DC (TDC) and DR (TDR) of a selected lumbar segment. Here TDC and TDR was
defined as the lowest observed stimulus amplitude producing a 100% response rate for
each population. Following the initiation of spontaneous sensory circuit activity, SCS of
10, 50, or 100 Hz with amplitudes of TDC or TDR was applied while recording activity in
LT/DH. Repetitive SCS was delivered intermittently (16s on, 4 sec off) for a period of 10
minutes. This was preceded and followed by a 20-minute period to establish a baseline.
The stimulation parameters were applied in a variable order for each experiment.
4.3.6 Data analysis
Spontaneous activity was quantitatively assessed by calculating the fast Fourier transform
(FFT) of 20-sec segments from LT/DH and DR recordings. The presence of one or more
sharp peaks was indicative of rhythmicity. FFT analysis was conducted using built-in MAT-
LAB (2019b) functions.
In all data presented, the number of animals utilized for analysis is represented by the
noted n-value. For each animal, a representative value was determined by averaging the
response from 6 sweeps/trials within that animal. Statistical significance of normalized
data was determined via ANOVA with Holm-Sidak multiple comparison test or a t-test,
depending on the data.
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Figure 4.1: SC-DRG preparation for studies of sensory circuit hyperexcitability.
A) Image of SC-DRG preparation pinned to a Sylgaard-lined dish following excision. Scale bar
= 5 mm. In the expanded view, the circles denote the location of DRGs with attached DRs, and
severed VRs. B) Schematic of experimental arrangement for LT/DH identification. DRG (circles)
attachment was maintained on one side to permit space for proper electrode placement. The distal
end of a lumbar DR was stimulated at long pulse durations during simultaneous recordings of the
DR entry zone and the LT region rostral to it. C) Examples of recordings observed during high
threshold stimulation in LT (left), the DH (middle), and the DR (right). 500 µs pulses recruited
C-fiber responses in the LT and DR and excitatory field potentials in the superficial DH. The gray
box denotes the stimulation artifact
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4.4 Results
4.4.1 Spontaneous, synaptically-mediated dorsal root activity is generated by 4-AP
Multisegmental spontaneous activity was generated following bath application of 4-AP,
which was broadly observed in DR, LT/DH, and DC populations (not shown). As our goal
was to first charachterize the 4-AP model of spontaneous circuit hyperexcitability, we first
focused our investigations on the recruitment of lumbar DR activity, as these recordings
are reliably expressed and was alway coupled with the presence of LT/DH activity. 4-AP
induced DRPs with overlying repetitive bursts (dorsal root reflexes [DRRs]) (Figure 4.2A).
DRP amplitude and frequency increased in a 4-AP concentration dependent manner (n=3,
Figure 4.2B). The average amplitude and frequency of DRPs was 13.2±2.1 µV and 1.1±0.4
Hz with 5 µM 4-AP. Raising the concentration from 5 µM increased the amplitude of DRPs
by average magnitudes of 1.9 (10µM, p<0.01), 2.8 (20µM, p<0.001), and 3.4 (30 and 40
µM, p<0.001). DRP frequency also increased by average magnitudes of 1.9 (10µM), 2.5
(20µM), 2.7 (30µM) and 3.2 (40µM) but was only significantly different at 40 µM (p<0.05,
Figure 4.2C). To investigate the role of central circuits in the observed spontaneous DR
activity, burst frequency with 30 µM 4-AP was quantified and compared when aCSF was
switched to a low-Ca2+ aCSF to limit synaptic transmission or following the addition of
10 µM BIC to block GABAA receptors (Figure 4.2D). The average burst frequency was
2.7±0.4 Hz with 30 µM 4-AP (n=4). This reduced by 53% (p<0.05), 64% (p<0.05), and
78% (p<0.01), for low-Ca2+ aCSF, 10 µM BIC, and 20 µM BIC, respectively (Figure
4.2E, F). In 2 of 3 experiments, the higher dose BIC (20 µM) completely blocked 4-AP
induced bursts. Thus, the emergent bursting involves a network of synaptically-connected
neurons whose DRP and bursting events involved activation of GABAA receptors.
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Figure 4.2: 4-AP induces spontaneous bursts and DRPs in DRs.
A) Example recording from a lumbar DR following bath application of 30 µM 4-AP. An example
burst is highlighted by the grey box (i) and the same burst is expanded before and after 100 Hz LP
(right, top) or 1000 Hz HP (right, bottom) filtering (ii) to observe the underlying DRP and DRR.
B) Example recording of spontaneous DRPs at 5 µM (top) and 40 µM bath application of 4-AP.
Each is a single trace after 100 Hz LP filtering. C) DRP amplitude and frequency increase with
higher concentrations of 4-AP. Each data point is the average across the population, normalized
to the magnitudes obtained at 5 µM 4-AP (n=3). Ordinary one-way ANOVA with Holm-Sidak
multiple comparisons test was performed to identify significant differences from 5 µM 4-AP [*,
p<0.05; **, p<0.01; ***, p<0.001] D, E) Burst frequency (generated with 30 µM 4-AP) is altered
by decreasing extracellular Ca2+ and reducing GABAA signaling with bicuculline (BIC). The top
black traces are recordings prior to switching to low Ca2+ aCSF (blue) or bath application of 10
and 20 µM BIC (grey). The displayed recordings are all single traces. F) low-Ca2+ aCSF (n=4) or
BIC (n=3) reduces burst frequency, initiated by 4-AP (30 µM). All data was normalized to baseline
values and t-tests were performed to identify significant differences from baseline [*, p<0.05; **,
p<0.01].
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4.4.2 Peripheral actions of 4-AP generate spontaneous spiking in primary afferents
In addition to the the circuit-based DRPs and bursting in DRs, spontaneous firing emerged
that appeared independent of the synaptically-mediated activity (Figure 4.3A). To deter-
mine whether these events originated in peripheral afferents we used an isolated minibath
containing 4-AP (˜30-50µM) and constructed around 3 to 4 lumbar DRs with attached
DRGs (Figure 4.3B). Recording of DRs with 4-AP exposure revealed the emergence of
spontaneous spiking activity, without the presence of repetitive bursts and DRPs (n=3). As
similar spontaneous spiking activity was seen when 4-AP (30 µM) was applied in the whole
bath preparation in the presence of a higher concentration of BIC (20 µM) (n=3, Figure
4.3C), we concluded they are peripheral in origin. To assess the classes of primary affer-
ents peripherally activated with 4-AP, we similarly isolated afferent activity (whole bath
application of 4-AP+BIC) and applied tetrodotoxin (TTX) at incremental doses known to
progressively block Aβ, Aδ, and C fibers [221][6]. Observations from these experiments
suggest that in addition to the spinal oscillations, 4-AP also initiates spontaneous firing in
some A and many C primary afferents (n=3, Figure 4.3D).
4.4.3 Spontaneous nociceptive activity is generated by 4-AP
As Lissauer’s tract and the subjacent substantial gelatinosa (LT/DH) prominently encode
nociceptive activity, extracellular recordings of LT activity strongly suggest that 4-AP (20
µM) produces spontaneous nociceptive activity. In LT this activity manifests as putative
Aδ (large) and C fiber (small) single-unit spikes (Figure 4.4A). When the microelectrode
is positioned below the surface of LT (LT/DH), nociceptive activity can manifest as spikes
and/or extracellular field potentials (EFPs) that reflect the population synaptic events from
the underlying superficial dorsal horn (Figure 4.4A). The average frequency of induced
nociceptive population events (fields with or without superimposed spikes) is 1.1±0.5 Hz
(n=7), while the frequency of nociceptive spikes independent of EFPs is 0.5±0.1 Hz (n=5).
Simultaneous recordings of lumbar LT/DH and the segmental DR revealed that the EFPs
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Figure 4.3: Peripheral actions of 4-AP produce spontaneous primary afferent spiking.
A) An example recording from a lumbar DR after 4-AP application (30 µM). Both DRPs (black tri-
angles) and spontaneous spikes (grey triangles) can be observed. B) An isolated minibath arrange-
ment was constructed to limit the exposure of 4-AP to peripheral aspects of the ex vivo preparation
(DRG & DRs). The green trace (top) was from a lumbar DR with 4-AP exposure and the black trace
(bottom) was from the contralateral DR. Spontaneous spiking was observed in the root with 4-AP
exposure. inset: magnified spike highlighted in the green trace (top) by the grey box. C) When
DRPs are blocked with a higher concentration of BIC (20 µM), single-unit firing is observed in the
L2 DR with bath application of 30 µM 4-AP, instead of bursts. inset: magnified spike highlighted by
the grey box. D) Selective block of spontaneously active afferents using concentration-based TTX
application suggests that 4-AP produces hyperexcitability in A and C fibers. The colored boxes
(right) display expanded regions of the recordings before (blue) and after 20 (green), 50 (red) and
500 nM (grey) TTX.
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frequently coincide with large DRPs observed in the DR, but on average are generated at
less than half the frequency of the DRPs (2.5±0.7 Hz, n=5). The events generated in LT/DH
and DR are rhythmic (Figure 4.4B), but lower frequencies (<2Hz) had greater contribu-
tions to the LT/DH activity, than what was observed in the DR (Figure 4.4C). Large bursts
in DRs can have two components (fast and slow), and the slow component appears to be re-
lated to large EFPs in the DH (Figure 4.4D). This suggests that spontaneous events induced
in the superficial DH produce antidromic bursts in slower conducting primary afferents (Aδ
and C), likely through primary afferent depolarization (PAD).
Activation of nociceptive circuits in the DH was confirmed with neuronal labeling for
the activity dependent reporter Fos. We compared Fos labeling in the pain-encoding su-
perficial dorsal horn under control conditions to that seen after electrical recruitment at C
fiber intensity (200 µA, 500 µs at 10 Hz for 10 mins) or after bath application of 4-AP (20
µM) for 10 minutes (Figure 4.5). Both electrical stimulation and 4-AP led to significantly
increase Fos labeling in the pain-encoding superficial dorsal horn. As expected for the
electrical stimulation experiment, Fos labeling was greater on the stimulated side, while
increases in Fos labeling with 4-AP were similar bilaterally.
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Figure 4.4: 4-AP produces rhythmic activity in LT/DH that can coincide with DR activity.
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A) Spontaneous nociceptive activity can be observed as repetitive spikes in LT (top) and/or field
potentials (EFP) from the underlying dorsal horn (bottom). B) Example of simultaneous recordings
of LT/DH and DR after bath application of 4-AP (20 µM). In this recording, the EFPs are observed
after large DRPs are generated in the segmental root. Spikes can also be observed that appear to
coincide with smaller amplitude DRPs/DRR. C) FFTs of the recordings from B reveal that both
LT/DH (i) and DR (ii) produce rhythmic activity, the largest frequency component is different for
each. For LT/DH the largest frequency contribution to the signal is at 0.13Hz, with other sharp
peaks at 1.2, 2.9, and 3.7 Hz. For DR, peaks at 1.2, 2.9, and 3.7 Hz are also observed but the largest
frequency component is at 3.7Hz. D) The slower component of large DR bursts coincides with EFPs
in the superficial DH. Displayed are raw recordings from the L3 DR (black) and L3 LT/DH (grey),
along with their associated spectrograms over the same time course. The bright green bands in
the spectrogram denote the timing of large events in both populations. The black triangles identify
the location of the fast burst in the DR, the green triangles denote the slow component. The slow
component in the DR coincides with a large EFP in the superficial DH.
Figure 4.5: Fos labeling confirms the selective activation of superficial DH neurons consis-
tent with activation of nociceptive circuits.
A) Few Fos+ cells were observed in the control condition (electrode placed with no stimultion). B)
Electrical stimulation the right L2 DR at high intensity (200 µA, 500 µs) at 10 Hz for 10 mins served
as a positive control for Fos labeling. 10 Hz stimulation of the RL2 DR at C-fiber threshold resulted
in Fos+ cells in the superficial DH of L2. C) Bath application of 4-AP (20 µM) also resulted in
Fos+ cells in the lumbar superficial DH. D) For the stimulation case, greater Fos+ cells were ob-
served in the DH ipsilateral to DR stimulation (n=1, average across10 sections); 2-way ANOVA
with Holm-Sidak multiple comparisons test was performed to identify significant differences be-
tween counts on the left and right sides of the DH of a single lumbar segment, [****, p<0.0001].
Preliminary evidence suggests that 4-AP (n=1, average across 7 sections) produces greater nocicep-
tive activation in the DH, than electrical stimulation. Very little nociceptive activation was observed
in control animals (n=2, average across 13 total sections), where an electrode was placed on the
right DR with no stimulation. Statistical analysis was not performed across groups, due to the small
sample size.
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4.4.4 Stimulus-independent nociceptive activity can be modulated by SCS
To investigate if SCS can modulate spontaneous nociceptive activity, we first identified the
stimulation intensity for consistent threshold recruitment for the DC and DR of a selected
lumbar segment (Figure 4.6A). We then, applied 10, 50 or 100 Hz stimulation at TDC or
TDR. The 2 min window following stimulation was analyzed to identify if SCS reduced
the frequency of nociceptive spikes or synaptic events (EFPs). Examination of spiking
activity during SCS (inter-SCS interval) revealed that 50 Hz stimulation at TDC reduced
nociceptive spiking by 54%, on average (n=4, p<0.05, Figure 4.6B, 4.6C). Interestingly,
this effect was not seen at the higher stimulation intensity required for Aβ fiber recruitment
at TDR. There were no parameters of SCS that produced prolonged modulation of spikes
in LT/DH and none of the examined parameters modulated EFPs during or after SCS (not
shown).
Figure 4.6: 4-AP induces spontaneous nociceptive activity that can be modulated by SCS.
A) Schematic of modulation experiments (left). Example SCS thresholds for DC (TDC) and
DR (TDR) were identified for subsequent experiments investigating modulation of LT/DH activ-
ity (right). Each trace is the average of 6 sweeps. The gray box denotes the stimulation artifact. B)
Example recordings of spiking activity in LT before (top) and during (bottom) SCS at TDC thresh-
old. Each trace consists of 6 overlying sweeps. C) SCS modulation of nociceptive spiking occurs
during 50 Hz stimulation at TDC but does not persist after stimulation. The data is normalized to
the spike frequency prior to stimulation (before). 2-way ANOVA with Holm-Sidak multiple com-
parisons test was performed to identify significant differences from baseline (before) [*, p<0.05]
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4.5 Discussion
Expanding upon our previous work, we demonstrated successful implementation of an
adult ex vivo mouse spinal cord (SC) preparation with intact dorsal root ganglia (DRG)
as a model system to study modulation of spontaneous hyperexcitability in nociceptive cir-
cuits . Permitting access to the DRGs, DRs, and SC at segments ranging from C8 to S1, this
system circumvents the accessibility issues that arise from in vivo preparations while allow-
ing greater interrogation of a more intact sensory system than typical in vitro and in vivo
preparations. Using this preparation and bath application of 4-AP, we generated a model
of stimulus-independent sensory hyperexcitability involving activation of neuropathic pain
pathways. Emergent activity was expressed as: (i) episodic population DRPs with super-
imposed burst firing in DRs, (ii) spiking in a pain tract (LT) with coincident population
synpatic events (EFPs) in the subjacent superficial dorsal horn (DH), and (iii) indepen-
dent spontaneous spiking events seen both in DRs and LT (Figure 4.7A). Interestingly, the
larger episodic population events observed in LT/DH were coincident with longer-lasting
DRP population activity seen in DR recordings. The timing of the longer-latency events
in the DRP and the onset of LT/DH activity suggest they originate from a common circuit
involving higher threshold afferents. These events occurred at a lower frequency. We did
not explore the synaptic circuit composition of episodic events recorded in LT/DH.
The frequency and amplitude of emergent episodic DRP/bursting activity in DRs was 4-
AP dose-dependent. DR bursting was dependent on synaptically-connected neural circuitry
as it was depressed when synaptic transmission was reduced using a low Ca2+-containing
aCSF. Episodic DRP/bursting was also dependent on activation of GABAA receptors as
burst frequency was depressed after application of a low dose of the receptor antagonist
BIC, and could be completely abolished at higher BIC dose. After the spontaneous DRPs
were suppressed, the remaining spontaneous firing in individual axons mirrored the axonal
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firing observed with selective application of 4-AP applied to locally isolated lumbar DRGs
and DRs. The population of single axonal units recorded was shown to consist of both A
and C fibers.
Spiking activity seen in DRs could arise from primary afferents themselves that then
lead to the DRP or from central circuits leading to dorsal root reflexes (DRRs) coincident
with DRPs. The DR spiking commonly appears after the onset of the primary afferent de-
polarization (PAD) responsible for the DRP, suggesting that they arise from central presy-
naptic inhibitory circuitry as DRRs. Overall, these observations demonstrate that rhythmic
bursting in DR is due to activity originating in the dorsal horn and propagated antidromi-
cally in dorsal roots. Coincident bursts of spiking and population synaptic potential re-
sponses recorded in LT and subjacent superficial dorsal horn associate DR activity with
recruitment of nociceptive circuits.
4.5.1 Neuronal activation and amplification with 4-AP
4-AP is a broad-spectrum voltage-gated K+ channel blocker [229], with the fast A-type
potassium current (IA) being more sensitive than the delayed rectified current (IDR) in
DRGs [230]. When formulated as a therapeutic (fampridine), 4-AP has demonstrated clin-
ical utility for improving motor symptoms following spinal cord injury (SCI) and multiple
sclerosis (MS) through suggested mechanisms thought to include restoration of conduction
in demyelinated axons, increased neuromuscular transmission, and facilitated recruitment
of spinal locomotor circuitry [225][231]. Unfortunately, 4-AP can also produce abdomi-
nal pain, and paresthesia in treated patients ([232][233]. These sensory abnormalities are
suggested to result from actions on cutaneous nerves and DRs [232][233].
In preclinical studies, 4-AP generates rhythmic epileptiform activity in hippocampal
slices [234][222] and spinal cord [231][235][223]. In the spinal cord, this is seen as
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synchronous bursts of activity in dorsal and ventral roots that originate from spinal cir-
cuits [231][235][223] [236]. Bursting activity tested in dorsal roots and superficial dorsal
horn was sensitive to inhibition of synaptic transmission [231] [223]. In spinal cord slice
recordings from juvenile rats, 4-AP has previously been shown to generate suprathresh-
old episodic bursting in superficial dorsal horn neurons including pain-encoding lamina
I spinoparabrachial projection neurons. It also unmasks polysynaptic C-fiber pathways
[223]. The same study observed preferential reduction in activity by anticonvulsants rather
than classical analgesics, further suggesting that 4-AP induces a neuropathic pain-like
phenotype. Building on this, the present work demonstrated similar episodic bursting
with 4-AP in our newly-developed adult mouse isolated spinal cord preparation. This
allowed the study of more intact neural circuitry and enabled us to explore the modula-
tory potential of SCS on a stimulus-independent hyperexcitability model expressing neu-
ropathic pain-like activity. 4-AP recruitment of nociceptive primary afferents was verified
with preferential block by high dose TTX. Additionally, 4-AP recruitment of nociception-
encoding spinal circuitry was confirmed by direct recordings of episodic activity from a
pain-processing tract (LT) that corresponded with subjacent population synaptic activity in
the pain-encoding superficial dorsal horn (EFPs), a region also selectively expressing large
increases in the activity-dependent marker Fos. Future studies should determine whether
this rhythmic activity is also preferentially sensitive to anticonvulsants over conventional
analgesics as reported in the Ruscheweyh and Sandkuhler (2003) study [223].
Consistent with earlier findings, we also observed that the frequency of induced DRPs/
bursting is depressed following partial block of synaptic transmission in low Ca2+- con-
taining aCSF and also significantly depressed or completely blocked following block of
GABAA receptors with BIC. Though most previous studies were conducted in neonate and
juvenile spinal cord slices, we have been able to reproduce some of these findings in our
adult, more intact preparation. While both neuronal and glial connexin proteins and gap
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junctions are also implicated in generating the emergent network oscillatory activity [235],
we have not yet tested the actions of gap junction blockers in our intact adult spinal cord
preparation.
Spontaneous primary afferent activity (A and C fibers) has been identified as a poten-
tial driver of neuropathic pain [50] [49] [51] [52] [54] [55] [35]. We sought to determine
whether 4-AP can lead to emergent spontaneous primary afferent activity, as the peripheral
actions of 4-AP are less defined. 4-AP application to peripheral nerve and DRs in vitro was
shown to produce regenerative firing and after-potentials in response to single evoked stim-
uli but stimulus-independent ectopic firing was not seen [232][233]. 4-AP was similarly
not observed to generate ectopic firing when applied directly to the nerve, but ectopic firing
was seen in all classes of cutaneous afferents when applied to nerve endings in a skin-nerve
preparation [237].
To determine whether 4-AP can produce spontaneous afferent activity, we applied 4-
AP on DRG and DRs in isolation using a minibath partition (Figure 4.3B). We observed
spontaneous activity emerge in dorsal root axons and used the differential sensitivity to pro-
gressively increasing doses of TTX to demonstrate that emergent activity originated from
A and C primary afferents. Unlike centrally-applied 4-AP, no episodic population activity
emerged. Compared to earlier studies our observed spontaneous firing is easily explained
by the presence of afferent cell bodies located in the DRGs of our preparation. 4-AP blocks
multiple A-type voltage-gated K+ channels expressed in DRG [228]. Importantly, reduced
DRG expression of A-type channels is seen in multiple chronic pain models [224]. While
this was typically associated with an evoked hypersensitivity, arterial injection of 4-AP in
an in vivo model of peripheral neuroma could induce ectopic firing in silent axons and
increase the firing rate of axons that were previously spontaneously active [238]. Paired
with our observation that 4-AP also induces spontaneous episodic activity in nociception-
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encoding spinal circuits (LT and superficial dorsal horn), we are in a strong position to
use our model system to study the effects of SCS on nociceptive hyperexcitability at both
central and peripheral sites of origin.
4.5.2 Modulation of stimulus-independent nociceptive activity
Previously (Chapter 3, [184]), we demonstrated that SCS recruits DC axons, at stimulation
amplitudes below the recruitment threshold for Aβ primary afferents of DRs. We hypoth-
esized that postsynaptic dorsal column (PSDC) tract cells could be the DC constituent
with the lowest recruitment threshold. Here, we investigated the potential for clinically-
analogous SCS to modulate spontaneous nociceptive activity in the SC-DRG preparation
and found that SCS preferentially modulated spikes during 50 Hz stimulation at TDC .
While none of the tested parameters of SCS modulated the frequency of episodic synap-
tic discharges (EFPs), 50 Hz SCS at TDC reduced the firing frequency of spontaneous spik-
ing in axons in LT but only during the period of stimulation (quantified at the inter-SCS
period). Modulation did not persist after the cessation of 50 Hz stimulation and did not
occur for any other parameters of SCS. To our knowledge, this is the first experimental
study to investigate SCS modulation of stimulus-independent nociceptive activity. As LT
contains axons of subjacent interneurons along with collaterals of Aδ and C primary affer-
ents ,and DH population responses were not affected, we assert that the depressed activity
seen is via modulation of primary afferent spiking.
We observed selective modulation of lumbar LT/DH spikes during recruitment of low
threshold DC axons but not at slightly higher stimulus intensities that would recruit DC
primary afferent collaterals. The assumed mechanism of action for SCS involves recruit-
ment of low threshold primary afferents (Aβ ) that activate inhibitory interneurons in the
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dorsal horn and prevents nociceptive transmission from lamina V WDR projection neurons.
Our findings indicate that PSDCs cells may contribute to SCS modulation of nociceptive
activity.
Though PSDC orthodromically project to DC nuclei, they also have local axon collater-
als in the spinal segment from which they originate [211]. It is possible that PSDC recruit-
ment activates inhibitory interneurons via their axon collaterals, and that these inhibitory
interneurons depressed on ongoing nociceptive activity to subthreshold levels resulting in
unchanged frequency of synaptic events but reduced frequency of spiking (Figure 4.6C,
4.7B). While this is what one would predict if SCS only functioned via the gate control the-
ory, modulation can persist for 30 minutes after SCS cessation clinically [82]. In vivo stud-
ies have also observed persistent modulation 30 minutes post-SCS [102][239]. Together,
this suggests that the prolonged modulation observed may be due to supraspinal systems
such as antinociceptive contributions from descending serotonergic circuitry [105][101][99].
Importantly, as modulation was not observed during SCS at an intensity that would recruit
the low threshold primary afferents our finding indicate that the presumed form of gate
control does not contribute to SCS modulation, and that antidromic activation of DC axons
alone cannot account for the modulation of chronic neuropathic pain.
Interestingly, spiking activity was not reduced with SCS at an intensity that also re-
cruited Aβ fibers. It has recently been shown that a population of amygdalar neurons en-
code a unique assembly of neurons that are necessary for producing the affective/emotional
dimension of pain [138]. Using a peripheral nerve injury model of neuropathic pain with
allodynia, they observed that recruitment of presumed Aβ fibers were now able to acti-
vate the pain encoding cells in the amygdala. Thus, rather than close the pain gate, Aβ
fibers may have unmasked projections that instead amplify pain. Regarding our work, sig-
nificantly reduced spontaneous activity— originally generated by SCS recruitment of DC
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axons below Aβ threshold (putatively PSDC cells; see 3.5.3)— is lost when Aβ fibers
are also recruited. This may be due to competing activation of nociception-reducing and
nociception-promoting pain circuit activation.
As the 4-AP induced rhythmic DH EFPs and DRPs may reflect a centralized parox-
ysmal form of neuropathic pain, our observations suggest that SCS would be ineffective
with the stimulation strategies attempted. Regardless, this initial study of SCS employed
a mechanistic approach with well-defined stimulus intensity and duration protocols to pro-
vide the first foray into SCS control of spontaneous sensory hyperexcitability. As such this
foundational investigation may serve as a launchpad for more detailed exploration of the
SCS parameter space for control of spontaneous nociceptive activity. Future studies may
assess whether different frequencies, stimulation patterns, longer duration stimulations or
higher stimulus thresholds would be more effective. For example, in a single trial with
higher intensity SCS stimulation at 50 Hz (anodic polarity, 200 µs pulse width at 200 µA
for 5 seconds every 20 seconds) led to lasting depression of episodic activity in LT/DH in
the intervening periods (not shown; n=1).
Traditional SCS employs frequencies ≤200 Hz with successful modulation obtained at
63Hz, on average [24][64]. Many preclinical studies use 50 Hz SCS to investigate modula-
tion of stimulus-evoked hypersensitivity [102][103][110] [95] [97][107] [100] [104] [239].
While projection neurons from the dorsal horn can have variable responses to different SCS
frequencies, one characteristic response consists of a non-monotonic frequency-response
relationship, where peak modulation is observed at 50 Hz [114]. Our model recapitulates
the frequency dependent nature of SCS modulation, as 10 and 100 Hz did not reduce synap-
tic or spiking events in LT/DH. A caveat of our studies is that recordings were obtained
at room temperature and we cannot exclude the possibility that frequency dependence of
modulation may be sensitive to differences in temperature given a temperature could clearly
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alter the spatiotemporal features of stimulus delivery.
Figure 4.7: 4-AP produces spontaneous activity that may be modulated by PSDC cells.
A) 4-AP produces distinct manifestations of spontaneous activity, depending on the site of action.
B) SCS may modulate spontaneous activity by recruiting PSDC cells (blue) that pre- or postsynap-
tically depress nociceptive circuits via inhibitory interneurons (black).
4.6 Conclusions
Here, we used an isolated SC-DRG preparation to determine if–in accordance with the gate
control theory–activation of Aβ collaterals in the thoracic DC was sufficient for modulating
spontaneous neuropathic pain-like activity in the lumbar spinal cord. We found that only
DC threshold (recruiting putative PSDC tract cells) SCS modulated nociceptive spiking,
during 50 Hz stimulation. Aβ (DR) threshold stimulation could not produce modulation for
any of the frequencies tested. We also found that none of the stimulation parameters were
able to reduce spontaneous synaptic nociceptive activity or produce prolonged modulation.
The findings suggest that antidromic actions resulting from DC axonal recruitment cannot
solely account for spontaneous pain modulation observed clinically.
4.7 Research Contributions
Tissue isolation, electrophysiology experimentation, and analysis was performed by Shaquia
Idlett-Ali. Fos experiments and histological processing and analysis were conducted by
Mallika Halder and Michael Sawchuk. Shaquia Idlett-Ali authored this chapter with col-
laboration from Dr. Shawn Hochman.
108
CHAPTER 5
CONCLUSIONS AND FUTURE WORK
5.1 Conclusions
The objective of this dissertation was to generate knowledge that leads to a better under-
standing of both neuropathic pain and pain relief provided by electrical spinal cord stimu-
lation (SCS).
In Chapter 2, I explored stimulus-independent physio-behavioral indices of ongoing,
neuropathic pain. For this work, noncontact electric field sensors were utilized with a tho-
racic contusion mouse model of spinal cord injury (SCI), known to generate mechanical
hypersensitivity. Examination of respiration rate variability (RRV) and sleep metrics (sleep
event number, sleep event duration, and brief arousal number) revealed significant differ-
ences from baseline, 6 weeks after SCI. I also found that spontaneous activity in the cell
bodies of primary afferents were greater in dorsal root ganglia (DRG) of the SCI group,
when compared to sham. The incidence of spontaneously active DRG in the SCI group
correlated with hindpaw mechanical sensitivity (50 % PWT), where a greater incidence
was observed in animals with lower PWTs. Incidence of DRG spontaneous activity was
also correlated with increases in the number of sleep events/ hour, indicative of greater sleep
segmentation for animals with a larger incidence of spontaneously active DRG. Observed
correlations between spontaneous sensory activity with evoked mechanical sensitivity and
sleep dysfunction support an important interplay between sleep and pain after SCI. DRG
spontaneous firing frequency, instead of incidence, was positively correlated with RRV. In-
terestingly, spontaneously active DRG incidence and firing frequency where not correlated,
suggesting that they may encode difference aspects of neuropathic pain. Overall, mea-
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sures of spontaneous afferent activity correlated with sleep segmentation, RRV, and paw
mechanosensitivity. As spontaneous afferent activity after SCI has previously been shown
to be causally linked with perception of stimulus-independent neuropathic pain [60], it is
plausible that afferent activity is also responsible for observed changes in respiration, sleep
and mechanosensitivity.
In Chapter 3, I developed an isolated adult mouse spinal cord for investigations of
axonal recruitment with SCS. To generate clinically-analogous stimulation in the mouse
model, I leverage finite element modeling to identify appropriate scaling of electrode di-
mensions and stimulation parameters to mirror the electric fields generated with clinical
SCS. Analogous electric field distributions were generated with 300 µm x 300 µm elec-
trodes positioned 200 µm above the dorsal column with stimulation between 50 and 200
µA. With simultaneous recordings in the lumbar dorsal column (DC), dorsal root (DR) and
Lissauer’s Tract (LT), I assessed antidromic axonal recruitment with SCS and found that
axons in the DC had the lowest recruitment threshold with faster conduction velocity than
the lowest threshold DR component. On average, DR and LT components were recruited
at 2.6 and 4.4 times the DC threshold, respectively. Importantly, these findings suggest
that the lowest threshold DC population recruited by SCS are not collaterals of Aβ primary
afferents, but instead arise from a non-afferent fiber population likely to be postsynaptic
dorsal column tract (PSDC) cells. Clinically, SCS generates paresthesias and pain relief;
and the previously assumed mechanism of action identifies Aβ primary afferents as the
source of both sensory phenomena. As PSDCs project to DC nuclei and have local axon
collaterals in the dorsal horn, my observations suggest that PSDC recruitment potentially
contributes to paresthesias and/or depression of pain perception.
In Chapter 4, I extend the isolated spinal cord preparation to include attached lumbar
DRGs to conduct the first known experimental appraisal of SCS modulation of stimulus-
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independent (spontaneous) nociceptive activity. To model spontaneous nociceptive activ-
ity, I employed bath application of the broad voltage-gated potassium channel blocker, 4-
aminopyridine (4-AP). Evidence that the 4-AP model led to recruitment of superficial dor-
sal horn spinal nociceptive circuits was confirmed using activity dependent Fos-labeling.
4-AP induced spontaneous activity that included rhythmic dorsal root potentials with su-
perimposed burst firing in dorsal roots. Rhythmic extracellular field potentials (EFPs) with
superimposed spikes in LT and subjacent dorsal horn were also observed and often corre-
sponded to events seen in dorsal roots. Pharmacological experiments additionally demon-
strated that single-unit firing arose from A and C primary afferents of the lumbar DR, and
were generated independently of central circuits. I then explored whether SCS at DC and
DR threshold could modulate spontaneous activity when tested at 10, 50, and 100 Hz.
Only DC threshold SCS at 50 Hz was found to modulate spiking activity in LT/DH, and
this occurred only during stimulation. There was no evidence of modulation of sponta-
neous synaptic events (EFPs) during or after SCS. Though in clinical studies SCS has been
demonstrated to generate prolonged modulation 30 minutes after cessation of stimulation,
this was not observed in my studies. Overall findings suggest that the recruitment of dorsal
column axons may not be sufficient for modulation of stimulus-independent neuropathic
pain. Further, SCS recruitment of Aβ fibers had no effect on spontaneous activity, contrary
to the assumed mechanism of Aβ fiber recruitment in gate control of pain. Figure 5.1
summarizing the major findings of this work.
Overall, this dissertation provides greater insight into the development of neuropathic
pain and the underlying mechanisms leading to pain relief with SCS. The findings support
further investigation of SCS stimulation parameters to modulate spontaneous nociceptive
activity.
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Figure 5.1: Summary of dissertation findings
I first found that peripheral sensory hyperexcitability is correlated with metrics of erratic breathing
(RRV) and segmented sleep (sleep event count), in an SCI model of neuropathic pain. Next, I ob-
served that a non-primary afferent population in the DC is recruited with SCS before Aβ primary
afferents in the DR. That population possibly consists of PSDC tract cells. Lastly, in a model of
spontaneous sensory hyperexcitability–that included spontaneous nociceptive activity, I found that
only DC threshold (TDC) SCS modulated spontaneous nociceptive spiking during 50 Hz stimula-
tion. Depression of spontaneous nociceptive synaptic activity and prolonged modulation was not
observed with any parameters. These findings suggest that SCS modulation can not solely function
via the gate control theory to produce relief of persistent spontaneous pain.
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5.2 Suggestions for Future Work
5.2.1 Mechanism of action: direction of new studies
In this dissertation ex vivo adult mouse preparations were used to study recruitment and
modulation with SCS. A benefit of transitioning studies to mouse models includes the
availability of genetic tools for cell-type specific targeting and modulation. In the ideal
scenario there would be an existing transgenic mouse line that would permit selective re-
cruitment of PSDCs via membrane expression of Channelrhodopsin (ChR). Such a tool
could be used in collision experiments to confirm that PSDCs are the lowest threshold DC
population recruited with SCS—evident by observation of optogenetic PSDC recruitment
blocking the low threshold DC volley observed with SCS. Selective optogenetic recruit-
ment of PSDCs would also help determine if maximal recruitment of these cells lead to
modulation of nociceptive activity in the model of sensory hyperexcitability.
Further exploration of SCS mechanisms would be enhanced by in vivo single-cell
recordings in the transgenic line that enables selective fluorescent labeling and recruitment
of spinal projection neurons [240]. Nociceptive signals originating in the periphery or the
spinal cord cannot be perceived if they are not transmitted to brain via spinal projection
neurons. As such, neuronal activity of projection neurons could serve as an indicator of
possible pain perception. Simultaneous recordings of spontaneous activity in dorsal roots
and projection neurons could further support the role of spontaneous primary afferent ac-
tivity in neuropathic pain states if NMDA antagonists reduce the spontaneous firing rate
observed for projection neurons. In vivo models would also enable investigations of de-
scending serotonergic contributions to SCS analgesia. If lesioning of the dorsal lateral
funiculus (DLF) [105] or the local application of serotonin receptor (5-HT2A, 5-HT3, and
5-HT4) antagonists [101] inhibit SCS modulation of projection neuron activity, it would
further define the importance of brainstem antinociceptive circuits and suggest that SCS
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should be optimized to recruit them.
5.2.2 Paresthesias and pushing past the plateau
The most important finding from this work is that the lowest threshold population of axons
in the DC produces partial modulation of spontaneous nociceptive activity in the spinal
cord, and that this population is unlikely to be collaterals of Aβ primary afferents. Dogma
assumes that in addition to the analgesia-producing antidromic actions, orthodromic ac-
tions of Aβ recruitment lead to paresthesias. Instead, PSDC recruitment with SCS seems
plausible given the corroboration of these preclinical findings with clinical observations.
In clinical studies, sensory threshold (producing paresthesias) was variable between
patients and body orientation-dependent [65][84]. But it typically coincided with the emer-
gence of a DC volley, as observed by epidural compound action potential (ECAP) record-
ings [65]. Discomfort threshold occurred at about 2 times the sensory/DC threshold and
was associated with the emergence of a higher threshold [65], presumed slower conducting
(smaller diameter) population of axons in the DC [84]. This higher threshold population
led to a feeling of “tightness”, not pain, alongside difficulty completing a motor task [65].
As this thesis showed that the lowest threshold axons are not afferent in origin, reported
discomfort threshold may instead be associated with recruitment of low threshold primary
afferents—possibly group Ia and/or Aβ axons. In my studies, DR primary afferents were
recruited at 2.6 times DC threshold and were slower conducting. Together it is reasonable
to suggest that paresthesias result from orthodromic actions of PSDC recruitment, not Aβ
primary afferents. As our results also demonstrate that more medial SCS electrode place-
ment provides greater separation of recruitment threshold between DC non-afferent axons
and Aβ primary afferents, medial electrode placements in clinical applications should per-
mit a greater range of SCS amplitudes subthreshold to Aβ /discomfort recruitment.
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In clinical settings, paresthesias serve as a rapid biomarker for therapeutic SCS. The
concordance of the paresthesia with the region of pain has been deemed necessary for
attaining analgesia, resulting in paresthesia-based optimization of parameters for tradi-
tional SCS. The variable success rates observed and the plateau in mean efficacy with
traditional SCS demonstrates the inconsistent nature of this biomarker for predicting suc-
cessful outcomes and the need for new parameter optimization approaches. EEG (elec-
troencephalography) and fNIRS (Functional Near-Infrared Spectroscopy) systems are non-
invasive, portable technologies that have been used to identify novel markers of pain activ-
ity in the brain. Most studies employed one or both of these technologies to explore indica-
tors of acute pain activity in healthy subjects [241][242]. Some explore evoked outcomes in
patients exhibiting neuropathic pain (fibromyalgia) [243][244] but no known studies have
investigated markers for ongoing, spontaneous neuropathic pain. If a novel neuropathic
pain “signature” could be identified by the hemodynamic and/or electrical activity of the
brain in resting states, it could provide an additional near real-time metric for SCS parame-
ter optimization in clinical settings. This alternative approach could provide a path toward
improved success rates, since parameters would also be optimized to alter this “pain sig-
nature”, instead of approaches reliant solely on the production of paresthesia overlap. If
history is any indicator, the current approaches to improve efficacy through changes in
the SCS technology itself (electrode design, frequency paradigms, etc.) are redundant and





PRECLINICAL EX VIVO FEA MODEL
Figure A.1: Preclinical ex vivo FEA model set up
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APPENDIX B
PRECLINICAL IN VIVO FEA MODEL
Figure B.1: Preclinical in vivo FEA model results
Electric fields in the spinal cord during SCS generated using a finite element model of the in vivo
mouse spinal cord. Comparable electric fields were observed with stimulation 200 µm above the
cord, at a low amplitude (50 µA) and 600 µm above the cord at a high amplitude (200 µA). Electric
field magnitudes (V/m, scales capped at ±50 V/m) are plotted over a cross-section of the spinal
cord directly underneath the midpoint of the stimulation bipole.
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